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Abstract
This thesis illustrates the ability of MARS photon counting spectral CT (SPCCT) to
identify and quantify intrinsic features of atherosclerotic plaque responsible for its rup-
ture.
Atherosclerosis is a disease in which plaque build-up in the arterial wall that can
rupture and cause luminal occlusion leading to vascular insufficiency to the end or-
gan. It is an ongoing degenerative process with grave consequences; necessitating
timely identification of rupture prone plaque for risk stratification and mitigation of
the disease. An estimated eight carotid endarterectomies are required to prevent one
stroke in symptomatic patients with severe carotid artery stenosis whereas 30 carotid
endarterectomies are required to prevent one stroke in asymptomatic patients. This
limited ability to select patients at risk of stroke and the numbers need to treat with in-
vasive and complex surgery that has an intrinsic risk of iatrogenic stroke has compelled
to find more efficient imaging technology. Works presented in this thesis illustrate an
effectiveness of MARS SPCCT in characterising different morphological components
of atheroma, essential parameters to distinguish rupture prone plaque from stable one.
Intrinsic characteristics of plaques were quantitatively and qualitatively evaluated in
MARS images and compared with histopathological findings. Individual experiments
explained in this thesis were designed to address research hypotheses while addressing
possible sources of biases. Data analysis were done with suitable statistical tests.
This research demonstrates the effectiveness of MARS SPCCT in atherosclerotic plaque
imaging. It also shows the traslational potential of MARS SPCCT for clinical appli-






ASIC: Application-specific integrated circuit
CD: Cluster differentiation
CERN: European organization for nuclear research
CSM: Charge summing mode
CT: Computed tomography
CTDIW : weighted average of dose across a single slice
CZT: Cadmium zinc telluride




LRNC: Lipid rich necrotic core
MARS: Medipix all resolution system
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MAC: Membrane attack complex
MD: Material decomposition
MRI: Magnetic resonance imaging
PCD: Photon counting detector.
PET: Positron emission tomography
SPECT: single-photon emission computerized tomography
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The aim of research presented in this thesis is to explore the diagnostic ability of
MARS technology in atherosclerotic disease. During my Ph.D, I made scientific con-
tributions in the form of journal publications, conference proceedings, poster presen-
tations, development of local and international collaborations, and establishment of a
new histopathological lab for our research group.




1. "First human imaging with MARS photon-counting CT."
Panta RK, Butler AP, Butler PH, de Ruiter NJ, Bell ST, Walsh MF, and the
MARS collaboration.
Published in IEEE Nuclear Science Symposium and Medical Imaging
Conference Proceedings, 2018.
This was the first human body part scanned by SPCCT. Astonishing diagnostic
quality images produced by MARS SPCCT resonated the scientific community and
was covered by all major news agencies, media outlets, newspapers and broadcast-
ing services as a major milestone in diagnostic imaging. My role in this study
was to help in creation, interpretation and comparison of MARS images with
that of other modalities (CT and MR) and to explore potential diagnostic utility
of MARS technology.
2. "Assessment of material identification errors, image quality and radiation doses
using small animal spectral photon-counting CT."
Marfo E, Anderson NG, Butler AP, Schleich N, Carbonez P, Damet J, Lowe C,
Healy J, Chernoglazov AI, Moghiseh M the MARS collaboration and Raja
xi
AY.
Published in IEEE Transactions on Radiation and Plasma Medical
Sciences. 2020.
This work investigates image quality of SPCCT and corresponding radiation dose
on small animals. It showed the potential reduction of effective radiation dose to
the patients without compromising image quality of SPCCT. From the beginning
of the research to the manuscript preparation, I was a part in interpretation and
analysis of the findings.
Manuscript in preparation
Currently, I am working on a manuscript to be submitted at another highly reputed
journal.
1. "Characterisation of intraplaque calcification in MARS imaging with histopatho-
logical correlation".
Dahal S, Searle E, Gieseg S, Raja AY, Butler AP, and the MARS collaboration.
Proposed submission at the “Radiology”, Journal of Radiological Soci-
ety of North America.
The amount of arterial calcification can determine the severity and outcome of
atherosclerotic disease. This study determines the effective energy spectrum of
X-ray photon for precise quantification of intravascular calcification. As a first
author, I played the major role in research design, its execution, interpretation of
findings and manuscript writing.
Book Chapters
I have contributed in this book chapter.
1. "Spectral Photon Counting Computed Tomography: Technology and
Applications:" CRC Press; 2020.
Raja AY and the MARS collaboration. In Ken Taguchi, Ira Blevis, and Kris
Iniewski (Eds.) ISBN 978-1-138-59812-6.
The chapter illustrates the technological aspect of SPCCT and its application in
two separate sections. The application part of the chapter explains imaging find-
ings of different tissues and/or disease conditions. I contributed in the application
part of this chapter by creating SPCCT images, interpreting them and explaining
their clinical significance.
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Peer reviewed conference proceeding/Paper
I have one international conference proceeding and directly or indirectly contributed
in four others of my co-workers.
1. "Histology of atherosclerotic plaque compared with tissue components measured
using a spectral photon-counting CT."
Dahal S, Searle E, Gieseg S, Raja AY, Butler AP and MARS collaboration.
Published in European Congress of Radiology (ECR) abstract book,
Vienna, Austria, 2020.
This qualitative study shows comparability of MARS images in identification of
different morphological features of atherosclerotic plaque with histopathological
reference standard. Research design, its execution (including both imaging and
histopathology), and abstract writing were done by me. Part of this study is
presented in Chapter 3 of the thesis.
2. "Assessment of metal implant induced artefacts using photon counting spectral
CT."
Amma MR, Butler AP, Raja AY, Bamford B, Butler P, Walker EP, and the
MARS collaboration.
Conference proceeding at International Society for Optics and Pho-
tonics , USA, 2019.
Metallic artifact obscure imaging findings in computed tomography. This confer-
ence proceeding explains the effectiveness of SPCCT on the metal implant induced
artefacts and compared it with existing imaging modalities like the CT scan. I
worked in the process of research designing, interpretation of images and evalua-
tion of result.
3. "MARS pre-clinical imaging: the benefits of small pixels and good energy data."
Butler PH and the MARS collaboration.
Conference proceeding at International Society for Optics and Pho-
tonics, USA, 2019.
Small pixel size improves spatial resolution. This conference proceeding illustrates
the effectiveness of small pixels and good energy data in obtaining sharp MARS
SPCCT images.
My role in this study was to help in developing the imaging protocol and evaluate
findings.
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4. "Cancer Imaging with Nanoparticles Using MARS Spectral Scanner."
Moghiseh M, Raja A, Kumar D, Panta R, Healy JL, Lewis J, AP Butler and the
MARS collaboration.
IEEE Nuclear Science Symposium and Medical Imaging Conference
Proceedings (NSS/MIC), Sydney, Australia, 2018.
Tumor imaging using nanoparticle contrast material is a promising field in medicine.
This study shows the effectiveness of SPCCT in localizing tumor cells in in-vivo
condition. I contributed in this research by working together with the principle
investigator in image processing, and its interpretation.
5. "MARS pulmonary spectral molecular imaging: potential for locating tuberculo-
sis involvement."
Lowe CD, Ortega A, Aamir R, Chernoglazov AI, Butler AP, Anderson NG, and
the MARS collaboration.
IEEE Nuclear Science Symposium and Medical Imaging Conference
Proceedings (NSS/MIC), Sydney, Australia, 2018.
Pulmonary tuberculosis is a major healthcare problem in the world as existing
imaging modalities can’t effectively diagnose the disease with certainty. This re-
search demonstrates the ability of SPCCT in identifying tubercular granulomas
in lungs. In this study, I collaborated with other authors in image interpretation
and lesion identification.
Published Abstract
There were two local and one international published abstracts with oral presentations.
I also contributed in three other published abstracts of my co-workers.
1. "Characterization of aortic valve calcification with MARS imaging."
Dahal S, Searle E, Gieseg S, Raja AY, Butler AP and the MARS collaboration.
Abstract published and presented at University of Otago symposium,
Christchurch, 2018.
This study shows an effectiveness of MARS SPCCT in identification of micro-
calcifications in the plastinated samples of the human aortic valve. Cadaveric
plastinated aortic valves were provided by Department of Clinical and Functional
Anatomy, School of Medicine, University of Otago Dunedin. Research design,
protocol setup, imaging, image interpretation and analysis were done by me. This
study was a local collaboration with School of Medicine, University of Otago and
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is explained in Chapter 5 of the thesis.
2. "Identification of intraplaque hemorrhage by MARS imaging."
Dahal S, Searle E, Gieseg S, Raja AY, Butler A and the MARS collaboration.
Abstract published and presented at University of Otago symposium,
Christchurch, 2019.
In this study, intraplaque iron was identified in MARS SPCCT images and com-
pared with histopathological images. Research design, its execution and abstract
writing were done by me. This work is explained in Chapter 3 of the thesis and
part of this work was also presented at European Congress of Radiology (ECR),
Vienna, 2019.
3. "Histology of atherosclerotic plaque compared with tissue components measured
using a spectral photon-counting CT."
Dahal S, Searle E, Gieseg S, Raja AY, Butler AP, and the MARS collaboration.
Published at European Congress of Radiology (ECR), Vienna, Austria,
2020.
As explained earlier, this qualitative study shows comparability of MARS images
in identification of different morphological features of atherosclerotic plaque with
histopathological reference standard. Research design, its execution (including
both imaging and histopathology) and abstract writing were done by me. Part of
this study is presented in Chapter 3 of the thesis.
4. "Quantification of various calcium crystals for gout, pseudo-gout and other arthropathies
using spectral photon-counting CT."
Sayous Y et al. [includes Dahal S].
Published at European Congress of Radiology (ECR), Vienna, Aus-
tria, 2020.
Crystal induced arthropathies are common cause of hospital visits worldwide. This
study shows ability of SPCCT in differentiating various types of crystal in the
joint. Currently, there are no reliable noninvasive tools to distinguish them from
each other.Thus, the findings of this study is of huge clinical importance. I partic-
ipated in this study and contributed in research design and image interpretation.
5. "Semi-automatic quantitative assessment of site-specific bone health using spec-
tral photon counting CT."
Matanaghi A et al. [includes Dahal S].
Abstract published at Journal of Nuclear Medicine, USA,2019.
xv
Assessment of bone health has clinical significance in various metabolic and de-
generative diseases. In this study bone health was accessed with the semiautomatic
segmentation of MARS SPCCT images. I worked with other co- authors in re-
search design and its execution , especially during image segmentation process.
6. "Spectral Photon-Counting CT Imaging of Gold Labelled Monoclonal Antibody
Drug Delivery to Raji and HER2 Positive Breast Cancer Cells - A Phantom
Study."
Lowe C et al. [includes Dahal S].
Accepted and published at Society for Biomaterials, Atlanta, USA,
2018.
In this study first ex-vivo cancerous cells were scanned. Thereafter, combined
gold labelled monoclonal antibody HER2 positive breast cancer cells were scanned.
It was found that SPCCT could effectively identify and quantify the amount of
targeted gold in the tumor. I worked with authors in image processing to identify
gold nanoparticles in breast cells.
Presentation (Oral)
During my PhD, I made nine (eight local and one international) oral presentations and
contributed on seven others of my co-workers.
1. "Characterization of aortic valve calcification with MARS imaging."
Dahal S, Searle E, Gieseg S, Raja AY, Butler AP and the MARS collaboration.
Presented at University of Otago symposium, Christchurch, 2018.
This study shows the effectiveness of MARS SPCCT in identification of micro-
calcifications in the plastinated samples of the human aortic valves which were
provided by Department of Clinical and Functional Anatomy, School of Medicine,
University of Otago Dunedin. Research design, protocol setup, imaging, image
interpretation and analysis were done by me. This study was a local collaboration
with School of Medicine, University of Otago and is explained in Chapter II of
the thesis.
2. "Identification of intraplaque hemorrhage by MARS imaging."
Dahal S, Searle E, Gieseg S, Raja AY, Butler A and the MARS collaboration.
Abstract published and presented at University of Otago symposium,
Christchurch, 2019.
In this study, intraplaque iron was identified in MARS SPCCT images and com-
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pared with histopathological findings. Research design, its execution and abstract
writing were done by me. This work is explained in Chapter 3 of the thesis and
part of this work was also presented at European Congress of Radiology (ECR),
Vienna, 2019.
3. "Clinical application of MARS imaging"
Dahal S, Searle E, Gieseg S, Raja AY, Butler A and the MARS collaboration.
Presented at Colloquium of Christchurch General Practitioner, 2019,
Ilam, Christchurch.
This was a 90 min. interactive presentation on possible use of MARS imaging in
clinical practice. The audience was a group of renowned general practitioners of
the city.
4. "Identification of intraplaque hemorrhage by MARS imaging."
Dahal S, Searle E, Gieseg S, Raja AY, Butler A, and the MARS collaboration.
Presented at 150 years anniversary symposium of University of Otago,
Dunedin, 2019 and Student Research Symposium- Te Wanaka Raka-
hau - koka 2019, Dunedin, New Zealand August 2019.
As stated earlier, in this study, intraplaque iron was identified in MARS SPCCT
images and compared with histopathological findings. Research design, its execu-
tion and abstract writing were done by me. This work is explained in Chapter 3
of the thesis and part of this work was also presented at European Congress of
Radiology (ECR), Vienna, 2019.
5. Three minutes thesis presentation,University of Otago, Christchurch, 2018.
Thesis work was presented in three minutes format to a diverse academic audi-
ence.
6. Three minutes thesis presentation,University of Otago, Christchurch, 2019.
Another, three minutes presentation of the thesis to an academic audience.
7. "Histology of atherosclerotic plaque compared with tissue components measured
using a spectral photon-counting CT."
Dahal S, Searle E, Gieseg S, Raja AY, Butler A and MARS collaboration.
Presented at European Congress of Radiology (ECR), Vienna, Aus-
tria, 2020.
This qualitative study shows comparability of MARS images in identification of
different morphological structures with histopathological reference standard. Re-
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search design, its execution, including both imaging and histopathology, and the
abstract writing were done by me. Part of this study is presented in Chapter 3 of
this thesis.
8. "Characterization of intraplaque calcification in spectral photon counting CT
with histopathological correlation."
Dahal S, Searle E, Gieseg S, Raja AY, Butler and MARS collaboration.
NZ MedTech Imaging Showcase, Christchurch, New Zealand, 2020.
The main aim of this observational study was to find an appropriate energy of
X-ray beam for precise quantification of vascular calcification. This study, which
is explained in Chapter 4 of this thesis, was designed, performed and presented
by me.
9. "Characterization of intraplaque calcification in spectral photon counting CT
with histopathological correlation."
Dahal S, Searle E, Gieseg S, Raja AY, Butler and MARS collaboration.
Presented on the behalf of MARS Bioimaging at Bio-engineering Otago
Showcase, Christchurch, New Zealand, 2020.
As stated earlier,the main aim of this observational study was to find an appropri-
ate energy of the X-ray beam for precise quantification of vascular calcification.
This study, which is explained in Chapter 4 of this thesis, was designed, performed
and presented by me.
10. "Gate Monte Carlo Dosimetry Simulation of MARS Spectral CT. "
Marfo E et al. [includes Dahal S].
Presented by Emmanuel Marfo on behalf of the MARS team at Geant4
User Workshop 2017, Wollongong.
As stated earlier, this work investigates image quality of SPCCT and correspond-
ing radiation dose on small animals. It showed the potential reduction of effective
radiation dose to the patients without compromising image quality of SPCCT.
From the beginning of the research to the manuscript preparation, I was involved
in creation, interpretation and analysis of findings.
11. "Cancer Imaging with Nanoparticles using MARS Spectral Scanner".
Moghiseh M et al. [includes Dahal S].
Presented by Mahdieh Moghiseh on behalf of the MARS team at IEEE
Nuclear Science Symposium and Medical Imaging Conference, Sydney,
Australia, November 2018.
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As mentioned earlier, this study shows the effectiveness of SPCCT on localization
of tumor cells. I made contribution in this research during image processing and
its interpretation.
12. "First Living Human Images from a ARS Photon-Counting 8-Energy CT."
Butler AP et al. [includes Dahal S].
Presented by Anthony Butler on behalf of the MARS Collaboration at
IEEE Nuclear Science Symposium and Medical Imaging Conference,
Sydney, Australia, 2018.
As stated earlier, my role in this study was creation, interpretation and compar-
ison of MARS SPCCT image with images of other modalities; MRI and CT to
explore its potential diagnostic utility.
13. "Advances in vascular imaging"
Gieseg S, et al. [includes Dahal S].
MedTech Imaging Showcase, Christchurch, New Zealand, December
2020.
This was an overview of recent advances on vascular imaging. I contributed in this
talk by providing content and power-point slides of MARS and histopathological
images from my thesis.
14. "To evaluate lipid concentration measurement with MARS spectral photon count-
ing CT."
Chapagain K et al. [includes Dahal S].
Presented by Chapagain K at NZMedTech Imaging Showcase, Christchurch,
New Zealand, 2020.
In this study phantoms consisting of a homogeneous mixture of water and lipid
with different concentrations were scanned to find accuracy and precision of MARS
SPCCT in quantifying fat concentration. I was involved in this project from phan-
tom development to scanning and data analysis.
15. "Brain imaging using spectral photon counting CT."
Matanaghi A et al. [includes Dahal S].
Presented by Matanaghi on the behalf of MARS team at NZ MedTech
Imaging Showcase, Christchurch, New Zealand, 2020.
Decapitated sheep’s heads were scanned to find the intrinsic features of brain and
also to identify different implants implanted inside the skull. Technical difficulty
we anticipated during scanning were large sample size with consequent huge data
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set to analyse. Nevertheless, we were able to scan the whole sheep head and
differentiate white and grey matter of the brain and identify different structures
within it. My involvement in this project consisted of image generation and their
interpretation.
16. "Human trial of spectral photon counting CT for wrist and hand injuries."
Clark J et al. [includes Dahal S].
Presented by J. Clark on the behalf of MARS team.
NZ MedTech Imaging Showcase, Christchurch, New Zealand, 2020.
This talk was about on-going human trial in MARS project. In this collective
work my contribution was patient evaluation, scanning, image processing and
interpretation of imaging findings.
Poster
In one poster my research input was equal with my co-worker whereas in the others I
contributed directly or indirectly.
1. "Intrinsic Respiratory Gating for MARS Imaging."
Asghariomabad F, et al. [includes Dahal S].
Presented at IEEE Nuclear Science Symposium and Medical Imaging
Conference,Sydney, Australia, November 2018.
This study illustrates correction of motion artifact in MARS spectral CT. I worked
with the the primary investigator to develop algorithm for retrospective correction
of breathing movements of mouse lungs. I contributed in analysing lung movement
for artifact masking. Presented by Fatemeh Asghariomabad on the behalf of the
MARS team.
2. "MARS Pulmonary Spectral Molecular Imaging: Potential for Locating Tuber-
culosis Involvement"
Lowe C, et al. [includes Dahal S].
Presented at IEEE Nuclear Science Symposium and Medical Imaging
Conference, Australia 2018.
This study shows the ability of SPCCT in identification of tubercular granulomas.
In the study I collaborated with other authors in image interpretation, lesion iden-
tification and data analysis. It was presented by Chiara Lowe on the behalf of the
MARS team.
3. "Determining soft tissue components of atherosclerosis using MARS spectral
xx
photon-counting CT."
Searle E et al. [includes Dahal S].
Presented at NZMedTech Imaging Showcase, Christchurch, New Zealand,
2020.
Presented by Emily Searle on the behalf of the MARS team. I was a co-author
with equal contribution in this project/ poster.
Collaborations




"Cadaveric aortic valve characterization with MARS Imaging."
Department of Clinical and Functional Anatomy, Dunedin School of Medicine,
University of Otago Dunedin.
Plastinated samples of Cadaveric aortic samples were provided by Department of Clini-
cal and functional anatomy, Dunedin School of Medicine, University of Otago, Dunedin.
I set up protocol, scanned specimen, analysed data, processed and interpreted images
Chapter 5 contains this collaborative work.
2. International collaborations:
1. "Components of Carotid Atherosclerotic plaque in Spectral Photon Counting CT
with histopathological comparison."
Collaboration with University of Cagliari, Department of Medical Sci-
ences and Public Health leading to joint publication.
This work, which is a major part of my research is the collaborative work with
University of Cagliari, Italy. I was a lead investigator in this study
2. "Utility of SPCCT on plaque imaging." Collaboration with University of
Edinburgh, UK.
This collaboration is with one of the largest cardiac imaging groups in the Euro-
pean Union. My role includes scanning of coronary arteries and aortic valves,
thereafter interpretation of imaging findings.
xxi
Industrial Collaboration
This research conducted under the University of Otago is part of a large collaborative
project with MARS Bioimaging Ltd., whose aim is to bring MARS scanners to the
clinics as a medical imaging tool. I have contributed in the following ways:
1. Development of vascular imaging protocol.
2. Testing multiple research scanners based at the University of Otago and Univer-
sity of Canterbury.
3. Development of histopathological protocol for validation of MARS images.
4. Phantom design.
Establishment of histopathological laboratory
Histopathological validation of imaging findings is essential in clinical radiology. In
my initiative, polarizing microscope, reagents and chemical were purchased. Tissue
processing machine and microtome were arranged. Above all, I took training, learned
histopathological procedure and applied acquired knowledge in my research. Estab-
lishment of the histopathological lab brings new capability in the team.
Training
I attended five lab based training courses crucial for histopathological work.
1. MPI Biological compliance training at University of Otago, Christchurch,
2018.
This mandatory training explained about legislation, standards, operating proto-
cols and procedure of laboratory work.
2. MPI Biological compliance annual re-fresher training at University of
Otago, Christchurch, 2019 and 2020
Mandatory re-fresher training.
3. Training on vascular histopathology at the Department of Pathology,
University of Otago, Dunedin, 2018.
This was a skill acquisition training on histopathological procedure which helped
me to establish histopathological lab and perform histology for my research.
4. Chemical awareness training at University of Otago, Christchurch,
2019.
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This was a part of health and safety training which provided essential knowledge
and skill on handling various types of chemical substances in the lab.
5. Chemwatch training at University of Otago, Christchurch, 2019.
This was a refresher course on chemical handling in the lab, prerequisite for
histopathological work.
Courses attended.
These courses were MedTech Core initiatives for capacity building of doctorate stu-
dents.
1. Instrumentation and Design , Auckland Bio-engineering Institute, Uni-
versity of Auckland, 2018.
This was a hands-on training in which participants designed and developed med-
ical instrument by themselves.
2. Computational Physiology, Auckland Bio-engineering Institute, Uni-
versity of Auckland, 2018.
Another hands-on training provided by Auckland Bio-engineering Institute in
which computational models were developed to study basic physiology of the human
body.
Learning support workshops:
I participated in these workshops organized by Otago University to support doctorate
candidates in their thesis writing.
1. Endnotes and thesis writing workshop, University of Otago, Christchurch.
This workshop taught technicality of thesis writing and referencing.
2. Embarking your doctoral journey workshop, University of Otago, Christchurch.
This was an introductory course on doctoral study.
3. Study skills workshop for new postgraduates, University of Otago,
Christchurch.
This workshop introduced study skill necessary for Ph.D.
4. Literature review workshop, University of Otago, Christchurch.
Literature search in google scholar, PubMed and use of MESH words were taught
in this workshop.
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5. Plagiarism and Paraphrase, University of Otago, Christchurch.
Plagiarism and academic dishonesty were explained in this course.
6. Presentation, University of Otago, Christchurch.
Effective ways of power point presentation were illustrated in this course.
Awards
For my Ph.D, I was awarded a doctoral scholarship and received funding to attend an
international conference.
1. University of Otago Doctoral scholarship, 2018.,
2. University of Otago travel grant to Participate in European Congress
of Radiologists, Vienna, 2020.
Professional registration
Registration at Medical Council of New Zealand (MCNZ) as a medical practi-
tioner with research scope of practice, 2020.
Continuous Professional Development (CPD) activity
"Ultrasonographic findings in renal parenchymal disease with histopathological correlation-
a hospital based cross-sectional study."
Dahal S, Pandit S.P, Khadka H and Bashnet S.B.
Published abstract with oral presentation at Royal Australian and New
Zealand College of Radiologists (RANZCR), 70t̂h Annual Scientific Meet-
ing, Auckland.
This study was part of my mandatory CPD activity set up by Medical Council of New
Zealand (MCNZ) and Nepal Medical Council(NMC). In this study, ultrasonographic
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The goal of this thesis is to study features of rupture prone atherosclerotic plaque using
MARS imaging, a spectral photon counting CT (SPCCT) technology, and explore its
traslational ability for clinical application.
1.2 Clinical relevance
Atherosclerosis is a systemic pathological process characterized by injury, inflammation
and lipid accumulation in the subendothelial space of vascular wall leading to thick-
ening, luminal stenosis, thrombosis, calcification and aneurysm formation Seidman
et al. (2014). It is responsible for numerous medical conditions including abdominal
aortic aneurysms, peripheral vascular disease with lower-extremity claudication, coro-
nary artery disease leading to myocardial infarction and stroke with or without carotid
artery stenosis Seidman et al. (2014).
Atherosclerosis presents with a spectrum of histopathological changes in the wall of
medium and large arteries Insull Jr (2009). Large lipid rich necrotic core (LRNC),
thin fibrous cap (FC), presence of intra-plaque haemorrhage, neovascularization, ap-
pearance of micro-calcification, and signs of local inflammation are all considered to be
features of plaque instability Shah (2003), Hellings et al. (2010), Mura et al. (2020).
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Chapter 1. Introduction
Unfortunately, available imaging modalities can’t effectively identify signs of plaque
vulnerability prior to events of vascular insufficiency and thus, only useful in post
incidence damage evaluation (Section 1.4). As a result of which clinical criteria for
preventive measures like carotid endarterectomy (CEA) are still primarily based on
the degree of luminal stenosis rather than intrinsic characteristics of the plaque Roth-
well et al. (2003).
Thus the search for new a imaging modality, which can effectively identify unstable
carotid plaque, vulnerable to rupture, led to the development of the MARS project,
part of which is funded by the Ministry of Business, Innovation and Employment
(MBIE) and the Ministry of Education through the MedTech CoRE.
The MARS scanner is a cutting edge imaging technology which can measure and dif-
ferentiate multiple materials (lipid, water, and calcium) using a low power x-ray tube,
photon counting detectors and narrow energy ranges in a single scan. The smaller pixel
size of the photon counting detectors (110 µm) enables visualisation and quantification
of intrinsic features of atherosclerotic plaque whereas its material decomposition (MD)
ability allows differentiation of those components from each other. In these scanners
images can be retrospectively reconstructed in isotropic voxel sizes ranging from 60 µm
to 500 µm MARS (2020).
Previous experiments have shown the effectiveness of MARS imaging in early detec-
tion of bio-markers of rupture prone atherosclerotic plaque (Figure 1.1) Zainon et al.
(2012) had shown that calcium, lipid, iron and water-like components of plaque have
distinguishable energy responses to X-ray, visible on spectral CT images. In this study,
they successfully showed that MARS SPCCT can identify and quantify calcium, lipid,
iron and water like materials in excised carotid arterial plaque . However, they were
not able to separate calcium from iron in atherosclerotic plaque using MARS scanner
because MD for iron separation was not reliable Zainon et al. (2012).In this study




In 2018, a colleague from our research lab was able to reproduce the same results with
120 kVp tube voltage and a detector with cadmium zinc telluride sensor layer Healy
(2018).
Figure 1.1: MARS material decomposed images of atherosclerotic plaque showing lipid core
(blue), calcification (white), lipid (yellow) and water (red).a Excised carotid artery. (b) Lipid
channel. (c) Calcium channel. d. Water channel with spotty clacifications (white dots). e.
Thin slice with all three channels (lipid, water and calcium) combined. f. Thick slice with all
three channels (lipid, water and calcium) Healy (2018).
With improved protocol (use of a cadmium zinc telluride sensor layer and broader en-
ergy range) Searle et al. (2018) showed that the large ferric nitrate concentrations were
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more reliable at accurately identifying the presence of ferric nitrate and can be sepa-
rated from calcium in MARS imaging. She was able to differentiate high concentration
of ferric nitrate solution from hydroxyapatite using in house material decomposition.
Same year, Prebble et al. (2018) identify iron in plaque as a marker of intraplaque
haemorrhage in MARS SPCCT mages. Even though quantification of iron in the pres-
ence of calcium using dual energy CT was reported earlier Wang et al. (2011), it was
the first time we were able to separate these two material using improved version of
material decomposition protocol in MARS scanner. Study performed by Searle was a
phantom based study without biological samples whereas studies by Zainon and Preb-
ble were proof of concept studies where sample size was small. This thesis explores
the potential of MARS technology in quantification of plaque components: fibrous
cap thickness, lipid rich necrotic core, iron and calcium quantitatively with adequate
sample size and validating those findings with histopathological results.
1.3 Principles of Imaging






Out of them, Photoelectric effect and Compton scattering are two predominant X-ray
interactions contributing to X-ray beam attenuation in computed tomography.
Photoelectric effect
The photoelectric effect occurs when a X-ray photon interacts an object with energy
just greater than the binding energy of the K shell, ejecting an electron from innermost
shell of an atom (Figure 1.4 ). Since it is an interaction with a bound electron, it is
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strongly dependent on the atomic number of the material and photon energy Allisy-
Roberts and Williams (2007).
Figure 1.2: Photoelectric effect. A X-ray photon eject inner shell electron in the atom and to
stabilize the atom, an outer shell electron fills the vacancy with secondary X-ray emission.
The probability of photoelectric absorption of X-ray is directly proportional to the
physical density of the object (ρ) and cube of its atomic number (Z). It is inversely
proportional to the cube of incidence photon (E).
Photoelectric absorption ∼ ρ(Z 3/E 3) (1.1)
Thus the probability of photoelectric absorption is higher when the energy of the
interacting X-ray beam is just higher than the binding energy of electron. If the x-ray
photon has less than electron binding energy, it can’t eject electron from the orbit.
Conversely, if the energy is too high the probability of an photoelectric absorption
significantly decreases due to its inverse relationship with the cube of the energy as




In Compton scattering the X-ray photon interacts with the valence electron or free
electron of the object (Figure 1.4) and gets deflected with various angles. Compton
scattering is a major cause of scattered radiation which depends on the electron density
of the material and weakly dependent on photon energy Allisy-Roberts and Williams
(2007).
Figure 1.3: Compton scattering. Production of low energy scattered X-ray when incident
X-ray eject valence electron
Attenuation and image generation in SPCCT
Attenuation is defined as the amount of X-ray deflected or absorbed by an object whose
value depends on the energy the of X-ray photon. Computed tomography creates an
internal structure of the object by acquiring attenuation values by exposing it from
different angles.
In spectral CT, a single energy spectrum is divided into separate energy ranges and
attenuation information is acquired from each of those energy ranges. Moreover, in
SPCCT, simultaneous sampling of the object across the different energy spectrum
16
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gives multiple energy dependent Hounsfield units which are then used to reconstruct
the interior appearance of an object by a computer Hounsfield (1973).
K-edge
In general, attenuation decreases with increasing energy of the X-ray photon. However,
as the X-ray photon reaches the binding energy of a K shell electron, it may eject it from
its orbit due to photo electric effect causing sharp increase in attenuation Pratt et al.
(1973). This abrupt increase of X-ray attenuation, called K-edge has an important role
in clinical imaging. K-edge of high Z materials lies within the diagnostic range thus is
widely used as a contrast material in diagnostic imaging.
1.3.1 Energy integrating detector(EID) and photon counting
detector (PCD)
Clinical CT uses Energy integrating detector (EID) in which detector elements are sep-
arated from each other by thin septa. Each of these detector element measures total
energy deposited within the specific time interval. Incidence photon first react with
upper part of the detector called as scintillator which is made up of material which con-
verts X-ray photon into the visible light. These visible lights then strike photodiodes
made up of semiconductor material which generate an electric signal. These electric
signals are proportional to the total energy deposited during the measurement interval
rather than energy of individual photon Willemink et al. (2018).
Photon- counting detector does not need scintillator layer to convert X-ray photon
to visible light. X-ray interacts with thick layer of semiconductor which generate a
cloud of negative and positive charge. Voltage applied on the semiconductor causes
charge to move causing electric signal. Photon counting detector registers individual
photon interaction Willemink et al. (2018).
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Figure 1.4: Schematic diagram of energy integrating detector. X-ray passes through reflector
layer and interact with scintillator which produces visible light photons. These light photons
deposit electric charge in the photodiodes creating an electric signal. Energy integrating
detector measures total energy produce by X-ray interaction.
Figure 1.5: Photon counting detector. X-ray photon interact with semiconductor which
generate charges collected in pixelated anodes. Electric signal is registered in different energy
spectrum.
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Advantages of photon counting detector over energy integrating detector.
1. Small pixel size: Energy integrating detector uses indirect conversion of x-ray thus
needs reflective layer between two pixels to prevent leak of signal. It limits the
ability to make smaller pixels in conventional CT. Relative increase in reflective
layer causes decrease in detector fill factor.
2. Energy discriminating ability: Since charge are registered in a separate energy
thresh hold, images can be created in the separate energy spectrum.
3. Electronic noise: Electronic noise which is significant in lower energy spectrum
can be excluded by discarding lower energy images.
4. Material decomposition ability: Simultaneous acquisition of attenuation values
of different materials in different energy threshold allows material identification
and quantification.
Challenges of photon counting detector: There are various technical challenges
needed to be address in Photon Counting Detector before it becomes main stream
modality of diagnostic imaging. Flux- independent effects like charge sharing and
charge tapping, or flux- depended effect of charge pile up can significantly deteriorate
spatial resolution and energy resolving ability of photon counting detector Taguchi
and Iwanczyk (2013). In photon counting detector transmitted X-ray beam is divided
into number of energy bins. Thus, number of X-ray photon in individual bin is less
than total number of X-ray which reaches detector which increases quantum mottling




Figure 1.6: MARS scanner : a. External look of the scanner b. Internal structure of the
scanner (Right picture)
Expect for in-vivo imaging all scan were performed in small bore MARS scanner ((Built
in 2011, Christchurch, New Zealand) ) which consists of a rotating gantry, MARS
camera, cabinet controller, x-ray source, computer hardware and software (Figure1.6).
A micro-focus x-ray tube of MARS scanner provides up to 120 kVp tube voltage and 350
µA tube current Source-Ray Inc Ronkonkoma (2019). It gives radiation dose CTDIW
of 5 mGy with beam width 15mm Butler et al. (2019).
Human in vivo imaging (Chapter 6) was done with a large bore, 70 mm diameter
MARS SPCCT scanner (Built in 2017, Christchurch, New Zealand) which uses the
same spectral CT technology platform for the acquisition of spectral CT data, image
reconstruction, material decomposition and visualisation as used on small-bore MARS
photon-counting CT was used.
The Medipix detector of MARS scanner is a photon counting detector capable of mea-
suring the attenuation of x-rays in various energy ranges. It is made up of CZT which
uses eight energy counters. One arbitration counter (base counter) which is set above
the pixel noise level to compensate the leakage current on the pixel by pixel basis. Four
inter-pixel communication enabled charge summing mode counters (CSM), and three
single pixel mode (SPM) counters without inter-pixel communication Ballabriga et al.
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(2013).
Figure 1.7: Medipix3 charge summing process: a. An X-ray interaction (100 keV) with the
photon counting detector. b.Charge sharing among four pixels, 10, 20, 30 and 40 keVs each
c. Medipix 3 detector summing total charge of interaction from four neighbouring pixels and
allocating total value (100 keV) to the pixel with highest chaege (40 keV).
As discussed earlier, charge sharing is a significant problem in photon counting detec-
tors where single high energy photons might be classified as one or more low energy
events which degrades image quality. A Medipix 3 detector addresses this issue with a
"charge summing" feature in which four neighbouring pixels communicate together and
locate the pixel with the highest charge for a quasi-incident interaction, the total charge
is then allocated to that pixel Hamann et al. (2014). Charge sharing feature of Medipix
3 is shown in Figure 1.7. The charge from the interaction is summed (10+20+10+60
keV) and the total value (100 keV) is allocated to the pixel with the highest charge (60
keV) for the incidence event.
Material decomposition and calibration phantoms :
In material decomposition (MD), identification of material is obituary; therefore, a
phantom of material of interest should be calibrated with the scanner. These phan-
toms are called calibration phantoms. Linear attenuation value of material obtained
at different concentration are recorded and are converted in mass attenuation value at
each energy spectrum and these series of spectral signatures are used as the calibration.
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The biological sample scans are then compared to these signals to determine content.
In spectral CT, attenuation patterns across the energies are used to determine the
material make- up of individual voxel Brambilla et al. (2017) . Material calibration is
done to estimate the concentration of material in each voxel. Thereafter, spectroscopic
linear attenuation pattern is compared to the calibration materials using a constrained
linear least squares algorithm Bateman (2014) . Individual voxel is assumed to con-
sist of two materials, water and one other calibration material that contributes most
strongly to the spectral response. Soft tissue voxel is the voxel with lipid and water
whereas voxels with other calibration materials are dimmed high Z voxel. Soft tissue
voxels are reported in concentration of lipid and water and high Z voxels are reported
in concentration of water and one of the high Z materials from calibration phantom
Bateman et al. (2018).
In this study, calibration phantom containing distilled water, oil and commercially
acquired different concentration of hydroxyapatite rods were used (Quality Assurance
in Radiology and Medicine (QRM) GmbH, Moehrendorf, Germany). Calibration phan-
tom of Ferric nitrates were prepared by Joseph L Healy on the behalf of MARS bio-
imaging Ltd. Different concentration of ferric nitrate solution were prepared by adding
known amount of iron fillings into fixed volume of nitic acid.
Fe + 6HNO3 =⇒ Fe (NO3)3 + 3NO2 + 3H2O
Lipid used was canola oil. Similarly, water was commercially obtained Milli-Q®
ultrapure water (Merck KGaA, Darmstadt, Germany).
Hydroxyapatite rods and water serve as bone-like and soft tissue-like material respec-
tively whereas ferric nitrates simulates hemosiderin.
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1.4 Available imaging modalities: strength and limi-
tation in atherosclerotic plaque imaging
Figure 1.8: Doppler sonography of carotid artery. a. Spectral wave with peak systolic value
of 367 cm/s and end diastolic value of 140.2 cm/s. b. Doppler criteria for measurement of
carotid stenosis (table). Hacking and Weerakkody (2018)
Figure 1.9: Contrast enhanced CT image of stenos of right internal carotid artery. a. 2D
image b. Volume rendering image Evans (2016)
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Doppler ultrasound of carotid artery, which is commonly used to characterize atheroscle-
rotic plaque and luminal occlusion, is useful in the initial evaluation of symptomatic
patients who present with nonspecific symptoms that may be related to stenotic or
embolic carotid stenosis LeFevre (2014). Degree of carotid stenosis can be estimated
in Doppler ultrasound with fair degree of accuracy by calculating the velocity of vas-
cular flow (Figure 1.8). Even though studies has shown that ultrasound can detect
echolucent areas in atherosclerotic plaque (representing necrotic core macrophages in-
filtration or hemorrhage) with reasonable level of sensitivity and specificity, detection
capability of fibrous cap thickness by ultrasound is too low to be of clinical use Gerrit
et al. (2010) . It has low spatial resolution with poor material identifying capacity.
Moreover, ultrasound is user dependent with higher degree of intra-observer variabil-
ity and inconsistency in reproducibility Arnold et al. (1999), making it not effective
enough to characterise intrinsic features of plaque vulnerability. Contrast enhanced
ultrasound is an emerging technology which has shown its usefulness in identification
of neovascularization in atherosclerotic plaque Coli et al. (2008). However it is still
in its early phase and more research is needed to get widespread clinical acceptability
Shah et al. (2007).
On the other hand, CT can effectively quantify vascular calcification and has been
used in the clinical practice for calcium scoring of coronary artery for a long time San-
giorgi et al. (1998). Potential use of CT in carotid calcification has been well established
Murgia et al. (2020) and is extensively discussed in Chapter 4 of this thesis. One of the
limitation of CT is it’s poor soft tissue contrast resolution which prevents it from ef-
fectively differentiate various morphological components of the atherosclerotic plaque.
Apart from high radiation dose, presence of intraplaque calcification (commonly at the
region of carotid bulb and/or proximal internal carotid artery) often hinders accurate
measurement of carotid lumen, essential for evaluation of severity of the disease. Fig-
ure 1.9 shows CT images with narrowed right internal carotid artery. As shown in the
picture, luminal narrowing can be well assessed in CT images, however components of
plaque are not visualised properly.
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Both contrast based and non contrast based MR angiography can be used to character-
ize vascular pathology (Figure 1.10 -left side) Gwak et al. (2020). Studies had shown
high sensitivity (range 80% - 84%) and specificity (range 90% - 98%) of MRI in de-
tecting plaque with American heart association (AHA) Class III-VII Cai et al. (2002).
Intraplaque haemorrhage was identified in MRI with mean sensitivity of 88%(range
82% - 96% ) and specificity of 80% (range 74% - 100% ) Saam et al. (2005), Puppini
et al. (2006), Chu et al. (2004). Similarly, lipid rich necrotic core was detected with
mean sensitivity of 94% (range 91% - 98%) and specificity of 79% (range 65% - 100%
) Yuan et al. (2001), Saam et al. (2005), Puppini et al. (2006). Fibrous cap status in
MRI was observed with high sensitivity (81%) and specificity (90%) Mitsumori et al.
(2003). Even intraplaque calcium was detected with mean sensitivity of 77% (range
76% - 80%) and specificity of 88% (range 86% - 94%) Saam et al. (2005), Puppini et al.
(2006).
Presence of vasa vasorum was shown in gadolinium contrast enhanced MR images
with mean sensitivity of 76% (76% - 83%) and specificity of 79% (75% - 79%) Yuan
et al. (2002) Kawahara et al. (2007). Aggregation of macrophages at atherosclerotic
plaque as a marker of inflammation can be found using super paramagnetic iron oxide
particles in MR imaging. It was shown that plaque with focal signal intensity loss after
paramagnetic iron oxide particles infusion is due to increase uptake of iron oxide parti-
cles by CD-68 and MAC-378 stained macrophages. Plaques with diffuse signal intensity
loss do not show such a correlation. MRI in conjunction of super paramagnetic iron
oxide can predict aggregation of macrophages with sensitivity of 63% and specificity
of 100% Kawahara et al. (2008). However, relatively long scan time of MRI increases
the chances of motion artifact. Magnetic resonance imaging (MRI) is expensive and
not easily accessible, limiting its use in day to day clinical practice.
Various studies have shown that radionuclide imaging are usefulness in risk stratifi-
cation of atherosclerotic plaque . Manca et al demonstrated high diagnostic accuracy
of indium labelled platelets in identification of thrombotic plaques with sensitivity of
89% and specificity of 100% Manca et al. (2001). Similarly, Annovazzi et al found ac-
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cumulation of 99mTc labelled interleukin-2 (IL-2) correlated with the amount of IL2R
positive cells which suggests presence of inflammation in carotid plaques Annovazzi
et al. (2006). Tawakol et al showed that 18F- flurodeoxyglucose positron (18F-FDG)
emission tomography can be used used to assess the severity of inflammation in carotid
plaques Tawakol et al. (2006). Similarly, McCabe JJ et al established that 18F-FDG
uptake by symptomatic atherosclerotic plaque can predict early recurrent stroke inde-
pendent of luminal narrowing McCabe et al. (2020).
Figure 1.10: a. MR angiography.Stenosis of left internal carotid artery and left vertebral
artery shown by arrows Yang et al. (2005) b. Digital subtraction angiography (DSA). Left
internal carotid artery stenosis Preston, David (2006).
Notably, Vesey AT et al. found 18F-fluoride PET/CT was more reliable in identification
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of rupture prone vulnerable plaque than commonly used 18F- FDG radio tracer Vesey
et al. (2017). Similarly, 68Ga-DOTATATE PET was found to be better in discriminat-
ing high risk against low risk plaque as compared to 18F- FDG PET Tarkin et al. (2017).
Digital subtraction angiography (DSA), which is considered to be a gold standard
of vascular imaging has high spatial resolution to accurately diagnose severity of lumi-
nal stenosis but fails to provide much needed information regarding the nature of the
plaque lesion. Besides that, it is an invasive procedure with high radiation exposure;
thus, is exclusively performed when combined with therapeutic intervention. Figure
1.10 (right side) is a DSA image which demonstrates severe narrowing at proximal left
internal carotid artery. Usefulness of dual energy CT in quantification of iron in the
presence of calcium was also reported Zhang et al. (2016).
1.5 Thesis outline
Chapters, in this thesis are arranged not in a chronological order of experiments but
according to the organ scanned. Chapters 2-4 contain study of the carotid artery,
whereas Chapter 5 illustrates aortic valves and finally Chapter 6 details in-vivo scan-
ning. Individual chapters of this thesis are hypothesis driven experiments and with the
identifiable objectives.
For validation, imaging findings were compared with histopathological reference stan-
dard. Samples were randomised and possible sources of biases were identified/addressed
wherever possible to ensure reproducibility of results. Finally, evidence thus produced
were directly applied on the human imaging as explained in Chapter 6 of the thesis.
This clear transition from ex-vivo pre-clinical experiments to the human imaging aligns
with the ultimate goal of MARS project to develop a commercial scanner for clinical
use.
Chapter 1: This chapter provides an introduction to the thesis. It includes clinical
relevance of this research and a brief description of the physics behind image produc-
tion and the MARS scanner.
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Chapter 2: In this chapter, morphological component of atherosclerotic plaque: fi-
brous cap and lipid rich necrotic core were quantitatively evaluated in 20 excised human
carotid arteries with MARS SPCCT and compared with histopathological standard.
Sample were selected with simple randomization and MARS SPCCT were interpreted
by independent radiologists to reduce observational biases.
Chapter 3: This is a qualitative analysis of intraplaque hemorrhage in MARS SPCCT
and histopathological images. Intraplaque iron was identified in two atherosclerotic
plaque samples which were then compared with histopathological findings.
Chapter 4: The area of eighteen calcified foci from ten randomly selected excised
human carotid atherosclerotic plaques were measured in five energy ranges and also in
material decomposed (MD) images of MARS SPCCT. Those images were compared
with representative histopathological sections.
Chapter 5: Cadaveric plastinated samples of human aortic valves were scanned in
MARS scanners. Results were evaluated quantitatively.
Chapter 6: This chapter consists of multiple transitional studies which ultimately
led to an in-vivo scanning of carotid artery.
Chapter 7: This chapter gives a conclusion to the thesis. It includes, research oppor-
tunities for upcoming PhD students and future possibilities that exists in this field to
be explored.
1.6 Research quality
To ensure quality assured research output, each experiment explained in this thesis has
gone through a rigorous external and local peer review process. The study presented in
Chapter 2 has been submitted to a leading cardiovascular imaging journal and Chapter
4 is at the final stage of full paper submission. Chapter 3 went through an abstract
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review process in European Congress of Radiology (ECR) and was presented at ECR,
Vienna 2020. Chapter 5 was presented at Otago University Symposium in 2019. Fi-
nally, Chapter 6 is the part of the clinical case series and will eventually be published
after its completion.
All experiments done in this thesis were novel. To my knowledge, there has not been
any publication similar to studies presented in this thesis. Therefore, results obtained
from this research are important milestones in advancement of the existing knowledge
on the effectiveness of SPCCT in atherosclerotic pathology.
1.7 Ethical approval
The atherosclerotic plaques were obtained from consenting patient undergoing Carotid
Endarterectomy at Christchurch Hospital under ethics approval CTY/01/04/036 granted
by the New Zealand Health and Disabilities Ethics Committee.
Similarly, plastinated aortic samples for MARS imaging had ethical approval from
Academic committee of University of Otago ( Ethics Committee reference number
H18/011).
Human scan on MARS scanner has ethical approval from New Zealand Health and
Disability Ethics Committee ( Ref.18/STH/221/AM01).
1.8 Candidate’s contribution
Hardware development was done by MARS engineers. Software for image reconstruc-
tion and visualization used in these experiments were in built software and commer-
cially available program (Image j). Imaging protocols (tube current, tube voltage,
energy bins, filtration and focal size etc.) were setup by the candidate. Image acquisi-
tion, interpretation and evaluation were done by the candidate.
Histopathology: In this study paraffin technique was performed. All together from
20 specimens around 1500 slides were prepared.
Three different staining protocols were used: Haematoxylin – Eosin, Prussian blue and
Alzarin red.
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All histopathological steps, fixation, dehydration and cleaning, embedding, sectioning,
and mounting were done by the candidate.
1.9 MARS team
Figure 1.11: MARS interdisciplinary team of physicists, radiologists, engineers, computer
scientists, orthopedic and other surgeons, mathematicians, biologists, and cancer researchers
The MARS team is a multidisciplinary team of physicists, medical physicists, clinical
radiologists, mathematicians, engineers, computer scientists, and biologists (Picture
1.11). Based at the Universityof Canterbury, the MARS group works alongside the
University of Otago and other associate partners. MARS has a major collaboration
with CERN in Geneva, where the Medipix detectors are developed.
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Fibrous cap and lipid rich necrotic
core of plaque
2.1 Introduction
The histopathological composition of atherosclerotic plaque is deterministic of their risk
of rupture and subsequent embolic events Shah (2003), Hellings et al. (2010), Mura
et al. (2020). At present, the severity of luminal occlusion is the only major criteria for
meaningful therapeutic intervention Hobson II et al. (2008), Weyer and Davis (2015).
Nevertheless, study of local plaque composition like Fibrous cap (FC) thickness and
Lipid rich necrotic core (LRNC) area has emerged as a new paradigm in vascular imag-
ing which have shown to be much more reliable as predictors of future cardiovascular
events Hellings et al. (2010). Characterization of these features can be crucial for risk
stratification in asymptomatic patients. Direct monitoring of intra-plaque changes can
also be useful in guiding future therapeutic strategies in symptomatic patients with
high risk carotid plaque phenotype.
The purpose of this study is to explore the potential of MARS SPCCT in identifi-
cation and characterization of these two important morphological components of vul-
nerable plaque (FC and LRNC) and compare them with histopathological reference
standard.
2.2 Significance
Existing imaging modalities have limitations in characterizing morphological features
of atherosclerotic plaque (Chapter 1). Thus, the significance of this study is to find
whether MARS SPCCT can overcome those limitations or not.
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2.3 Contribution
Study design, MARS imaging, image processing, histopathological slides preparation,
microscopy, data acquisition, data analysis and interpretation were done by me.
2.4 Research hypothesis
This study was carried out with the null hypothesis that there is no difference between
MARS SPCCT and histopathology while measuring the morphological components of
carotid atherosclerotic plaque.
2.5 Objective
To compare the size of fibrous cap and lipid rich necrotic core measured by MARS
SPCCT with those measured by histopathology.
2.6 Methodology
2.6.1 Study design and sample population
This observational ex-vivo prospective study was conducted between February 2018
and January 2020. A total of 20 excised carotid atherosclerotic plaque specimens from
patients who underwent carotid endarterectomy at Christchurch hospital over the two
year period were included. Specimens were selected by simple randomization from the
pool of samples stored at -80 C. The study was approved by the Southern Regional
Health and Disability Ethics Committee. All patients participating in this study gave
written informed consent to participate. For imaging, specimens were thawed at room
temperature and scanned with a small bore spectral photon counting CT scanner.
Thereafter histopathological slides were prepared (Appendix A).
2.6.2 MARS Imaging
The imaging was performed using a small bore MARS scanner. Specimens were scanned
individually in an ordinary falcon tube with the image acquisition protocol specifically
optimized for plaque imaging; 118 kVp/19µA and 720 projections @100ms exposure
time. Material decomposition (MD) algorithm was applied for qualitative discrimina-
tion of fat, soft tissue and calcium (Figures 2.13, 2.14, 2.15, and 2.16). Five energy
thresholds with an integrated charge-summing mode were set at 7, 18, 30, 45 and 75
keV resulting in five energy channels (7–18, 18–30, 30–45, 45–75 and 75–118 keV).
Image reconstruction was performed using an in-house developed iterative reconstruc-
tion algorithm at 90 µm isotropic voxel size. The FOV was 52 mm with an image
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matrix size of 62.7 x 62.7 mm. Reconstructed energy images were first converted into





Where µX is a linear attenuation of plaque, µwater is linear attenuation of water and µair
is linear attenuation of air. The material decomposition (MD) algorithm was applied
for qualitative discrimination of fat, soft tissue, and calcium (Figures 2.13, 2.14, 2.15,
and 2.16).
Figure 2.1: Attenuation characterization of plaque by MARS Spectral Photon Counting CT
(SPCCT) in Hounsfield Unit (HU) at selected Region of Interest (ROI. a. figure shows ROI at
the medial wall of Rt. Internal Carotid artery, 90 µm coronal section. b. The histogram shows
distribution of voxels in the ROI at 45-75 keV energy bin. Unit/voxel (HU). c. Distribution
of lipid containing voxels (<0,>-100) at the ROI at different energy bins.
In order to quantify different morphological features of plaque specimens, region of
interest were selected from visually low attenuating areas at the center of the plaque,
as shown in Figure 2.1a, and line profiles Figure 2.2a plotted across all energy bins.
Figure 2.1b shows a large number of voxels containing lipid attenuation (HU < 0) at
the center of the plaque. Furthermore, Figure 2.1c shows a decrease in the number of
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lipid containing voxels with increasing energy bins.
It is evident that lipid signal is more distinguishable at lower energy bins suggest-
ing effectiveness of low energy photons in its identification. Although we used all five
energy bins for data analysis, energy bin 45-75 keV was used for demonstrative purposes
in the figures as it provides relevance to the diagnostic energy range.
Figure 2.2: Line profile a. Region of interest at the medial wall of right internal carotid artery
b. Graph showing identification of different regions of plaque based on their attenuation
value. Each blue dot represent Hounsfield/voxel. Unit/voxel (HU). c. Thickness of different
morphological regions of plaque at different energy levels. LRNC= Lipid Rich Necrotic Core.
Figure 2.2b. shows line profile fluctuations in HU to characterize thickness of different
intraplaque regions based on zero HU threshold. For example, the FC region was
characterized as the region with all voxels containing positive HU, whereas the LRNC
region was identified from the first voxel with negative HU to the voxel with positive
HU. Finally, the external wall of the artery was characterized by voxels containing
positive HU only. The thicknesses of these intraplaque regions were measured by
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multiplying the number of voxels in those regions with known voxel size of 90 µm
(Figure 2.2c). These line profiles were drawn for all 18 plaque specimen at specified
regions and average of fibrous cap thickness were calculated for all specimens.
2.6.3 Histopathological slides preparation
Specimens were fixed with 9% formalin for 72 hours. They were then decalcified with
weak formic acid for 2 days. Thereafter, samples were neutralised with lithium carbon-
ate solution for 2 hours. Specimens were then embedded in paraffin and longitudinally
cut into 4 µm slices at every 5 mm interval (Figure 2.3).
Figure 2.3: Histopathological procedure. Image shows consequential processes of histopatho-
logical procedure.
Haemorrhagic plaques were excluded from observations, to rule out the confounding
effect of hematoma while evaluating plaque components. Non haemorrhagic plaques
were de-paraffinised with xylene solution and washed with absolute alcohol. Descend-
ing concentrations of ethanol were used to re-hydrate specimens. Thereafter, they were
stained, dehydrated with ascending concentrations of alcohol and washed with xylene.
Finally, slides were mounted with cover slips. Haematoxylin & Eosin stained micro-
scopic images were used to compare different components of plaque with corresponding
MARS SPCCT images (Figure 2.4). Specimens were stained with Perl’s Prussian blue
to identify intraplaque haemorrhage (Figure 2.5). Detailed histopathological protocol
is explained in Appendices A.
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Figure 2.4: Atherosclerotic Plaque of the Right Internal Carotid Artery a. Photographic
image b. Volume rendering SPCCT MD image c. 90µm coronal SPCCT section, yellow
oval represents medial wall of the artery d. Histopathological image: H&E stained 4µm (x5
magnified) coronal section of medial wall of the artery
2.6.4 Comparison of MARS SPCCT and corresponding histopatho-
logical images
Figure 2.5: Hemorrhagic plaque. a. Excised carotid artery specimen with atherosclerotic
plaque b. Hemosiderin positive blue area in Prussian blue 4 µm histpopathological section.
Haemorrhage was identified by Perl’s Prussian blue stain in histopathological sections
to ensure a non-haemorrhagic slices were used for comparison (Figure 2.5).
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Thirteen plaques, which were either Type III or IV with distinct lipid pools, were
compared for LRNC area and 18 plaques with identifiable FC were compared for FC
thickness and area.
Figure 2.6: Comparison of 75 keV coronal MARS SPCCT images with corresponding Haema-
toxylin & Eosin stained 4 µm longitudinal histopathological slides(x5 magnification) a. Region
of interest at medial wall of right Carotid Artery in MARS SPCCT(left) and corresponding
histopathological image (Right) b. Measurement of fibrous cap thickness at the region of in-
terest in the MARS SPCCT image (left) and histopathological image (Left) c. Measurement
of Lipid Rich Necrotic Core area in the MARS SPCCT image (Left) and histopathological
image (Right) d. Measurement of fibrous Cap area in the MARS SPCCT image(Left) and
histopathological image(Right)
Two consultant radiologists with experience in vascular imaging independently evalu-
ated images of all plaque specimens in two separate sessions. To perform analysis on
FC thickness, FC area, and LRNC area, radiologists used sagittal sections of 45-75 keV
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MARS SPCCT images. For FC thickness, multiple line profiles (as shown in Figure
2.6b) were drawn to quantify the distance from the first soft tissue voxel (>0 HU) to
the first lipid containing voxel (≤ 0 HU). The median value of FC thickness was calcu-
lated for each plaque. FC and LRNC areas were also evaluated for all plaque specimens
in the same window settings (Figure 2.6 c, d). MARS SPCCT and histology images
were visually matched with each other for comparison. Landmarks like distance from
carotid bifurcation, prominent area of calcification, and /or luminal shape were used to
find regions of interest at identical histopathological and MARS SPCCT images.
2.6.5 Data analysis:
The research hypothesis was tested with Wilcoxon signed-rank test. Correlation was
calculated with kendall tau rank correlation. Skewed distributions of data sets were
normalized using log or square root transformation, thereafter, the limit of agreement
between MARS SPCCT and histopathology were presented in Bland–Altman plots.
Linear regression between mean measurements and differences values, were performed
to identify the presence or absence of proportional biases in Bland-Altman plots. Intra-
class correlation coefficients (ICC) for inter and intra-rater reliability were calculated for
two independent radiologists. Statistical significance was set at two tailed p<0.05.
2.7 Observation and results
Carotid atherosclerotic plaques of 20 patients were evaluated (Figure 2.12). Two haem-
orrhagic carotid samples were dropped from the study after histopathological exami-
nation (Flow chart 2.7).
Out of 20 specimens, 13 were preatheroma (type III) or classical atheroma (type IV).
The remainder were either type Va or Vb plaques (Figure 2.12) ( Figures 2.13, 2.14,
2.15 and 2.16) Stary et al. (1995). Out of 20 patients, 13 were male; 7 patients were
>80 years; others were between 60 to 80 years (Figure 2.8). Overall, 11 patients were
hypertensive, 4 were smokers and 3 were suffering from diabetic mellitus (Figure 2.9).
All 20 patients were on antilipidemic treatment. 8 were admitted with stroke; 6 with
Transient Ischemic Attack (TIA); 3 patients had Amaurosis Fugax and one patient had
more than one diagnosis ( stroke,TIA or amaurosis fugax) (Figure 2.10). On Doppler
Ultrasonography, occlusions were distributed between left and right internal carotid
arteries equally (left = 9) ( Figure 2.11). One patient had severe occlusion in the right
Common Carotid Artery (CCA). 13 patients had severe luminal occlusion (70-99%),
while 7 patients had stenosis of < 70% ( Figure 2.12 ) Grant et al. (2003).
38
2.7. Observation and results
Figure 2.7: Sample selection and exclusion.
Atherosclerotic plaques of 20
patients, who underwent carotid
endarterectomy at Christchurch
Hospital were evaluated (N=20)
All 20 plaques were scanned
by MARS SPCCT (N=20)
Histopathological slides were pre-
pared from all 20 plaques (N=20)
2 Perl’s Prussian blue positive
haemorrhagic plaques were excluded
Histopathological images of remaining
18 plaques were compared with
corresponding MARS SPCCT (N=18)
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Figure 2.8: Demography of patients evaluated. Pie chart in left side shows gender breakdown
of patients. Bar graph in right side shows age breakdown of patients.
Figure 2.9: Breakdown of three major preexisting conditions in patients.
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Figure 2.10: Breakdown of clinical manifestation of disease. (More than one diagnosis is
combination of either stenosis, TIA or amaurosis fugax.)
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Figure 2.11: Pie chart shows breakdown of location of stenosis (LT.ICA = Left internal
carotid artery, RT.ICA = Right internal carotid artery (CCA = Common carotid artery) and
bar chart shows severity of carotid occlusion as seen by ultrasonography (USG).
Figure 2.12: Breakdown of histological type of plaques.
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Figure 2.13: Type III plaque- pre-atheroma with extracellular lipid pools a. Photographic
image b. MARS SPCCT material decomposition image ( fat represented by yellow, water by
red and calcium by white color) white circles represent individual lipid pools c. Histological
longitudinal section of 4 µm thickness; black arrows represent corresponding lipid pools.
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Figure 2.14: Type IV plaque- atheroma with confluent extracellular lipid core a. Photographic
image b. MARS SPCCT material decomposition image (fat represented by yellow, water by
red and calcium by white color) white circle represents lipid rich necrotic core region c.
Histological longitudinal section of 4 µm thickness; white circle represents corresponding lipid
rich necrotic core region.
Figure 2.15: Type Vb plaque- calcification predominated plaque a. Photographic image
b. MARS SPCCT material decomposition image (fat represented by yellow, water by red
and calcium by white color); white circle represent calcium containing region of interest. c.
Histological longitudinal section 4 µm thickness; black arrow shows calcium in the region of
interest.
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Figure 2.16: Type Vb Plaque- fibrous tissue predominant, absent or minimal lipid core. a.
Photographic image. b. SPCCT material decomposition image (fat represented by yellow,
water by red and calcium by white color); white circle represent fibrous tissue containing
region of interest. c. Histological longitudinal 4 µm thick section shows fibrous tissue in the
region of interest.
Wilcoxon signed-rank tests of histopathological and SPCCT measurements of FC thick-
ness and FC area by two radiologists, consistently showed that there was no significant
difference between the values obtained from the SPCCT images and the corresponding
histological images (p values >0.05).
Table 2.4: Wilcoxon signed - rank test of histopathological and MARS SPCCT measurements











p= .17 p= .51 p= .15 p= .23
Fibrous cap
area
p= .053 p= .16 p= .12 p= .30
Lipid rich necrotic
core area
p= .36 p= .18 p= .01 p= 0.38
Note: MARS SPCCT = MARS Spectral Photon Counting CT. p = p value
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Table 2.1: Histopathological and MARS SPCCT measurements of fibrous cap thickness by










.72 .72 .81 .81 .49
.21 .15 .23 .24 .01
.27 .18 .44 .54 .42
.32 .31 .31 .27 .23
.47 .39 .53 .54 .56
.29 .22 .26 .29 .34
.33 .42 .50 .42 .49
.97 1.00 .93 .82 .63
.39 .36 .34 .27 .25
.63 .63 .56 .45 1.20
.51 .55 .47 .27 .63
.32 .31 .35 .30 .18
1.14 .92 .94 1.00 .93
.40 .15 .10 .40 .02
.15 .15 .17 .09 .17
.49 .39 .30 .26 .29
.40 .40 .34 .42 .34
.17 .18 .11 .21 .09
Note: Values are in mm.
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Table 2.2: Histopathological and MARS SPCCT measurements of fibrous cap area by two










7.80 7.80 5.40 6.10 3.50
5.50 3.50 3.00 3.00 .01
.38 .46 .55 .96 .61
3.70 3.60 3.50 2.80 3.10
1.20 .65 .70 1.20 1.40
.36 .13 1.80 2.30 2.16
4.30 7.80 1.80 2.90 3.00
1.80 .96 3.20 1.60 1.23
6.90 7.00 7.50 5.10 7.20
3.00 2.00 1.90 .80 1.80
1.30 1.43 1.70 1.50 .14
.45 .30 .38 .30 1.15
2.10 .42 .70 .73 .66
.88 1.16 1.40 1.40 .42
.46 .62 .51 .93 .20
1.26 1.70 .81 2.80 .10
.72 1.55 1.56 .45 .68
.77 .83 .36 .86 .98
Note: Values are in mm2.
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Table 2.3: Histopathological and MARS SPCCT measurements of LRNC area by two radiol-










9.50 11.30 9.80 7.80 7.60
1.60 1.50 3.80 1.00 1.70
2.00 3.40 6.00 3.00 2.40
.81 .70 .90 .61 .49
2.15 5.90 5.40 4.20 4.70
.96 1.20 1.40 1.40 1.40
8.30 12.20 16.20 18.40 12.20
5.90 10.70 19.50 16.10 10.80
2.37 2.21 2.10 2.00 3.27
.62 .50 .94 1.60 2.16
33.20 23.00 43.80 43.00 28.30
2.30 2.40 3.90 2.30 2.00
2.10 1.90 1.70 1.70 1.40
Note: Values are in mm2. LRNC= Lipid rich necrotic core












0.57 0.71 0.72 0.55
Fibrous cap
area
0.25 0.14 0.36 0.17
Lipid rich necrotic
core area
0.68 0.78 0.76 0.83
Note: MARS SPCCT = MARS Spectral Photon Counting CT.; p = <.001.
For LRNC area, Wilcoxon signed-rank test was statistically non-significant (p values
> 0.05) in all cases except one (Table 2.4). Strong correlation between MARS SPCCT
and histopathology was observed while measuring LRNC area and FC thickness with
Kendall tau consistently above 0.5, whereas for fibrous cap area it is weak (< 0.5)
(Table 2.5).
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Figure 2.17: Limit of agreement between MARS imaging and histopathology-fibrous cap
thickness.
Figure 2.18: Limit of agreement between MARS imaging and histopathology- fibrous cap
area.
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Figure 2.19: Limit of agreement between MARS imaging and histopathology.
Bland-Altman plot for FC thickness showed that 33% of the measured values were
within the 95% limit of agreement for SPCCT and histopathology, whereas this was
substantially higher for LRNC area, 53% and remarkably lower for FC area, 16% (Fig-
ures 2.17, 2.18, 2.19). Moreover, the trend for LRNC area showed stronger agreement
whilst measuring larger necrotic cores (Figure 2.19). The mean difference and 95%
confidence interval for FC thickness, FC area and LRNC area measurements were 0.04
(-0.03 to +0.12) square root mm, -0.18 (-0.34 to -0.02)log10mm2 and 0.009 (-0.08 to
+0.10) log10mm2 , respectively (Figures 2.17, 2.18, 2.19).
Inter and intra reader reliability between radiologists for FC thickness, LRNC
(ICC=0.9/reader) and for FC area (ICC=0.8/reader) were excellent (Table 2.6). Sim-
ilarly, inter-reader reliability between two different radiologists were also excellent
(ICC= 0.9) for all parameters measured in MARS imaging. However, a wide con-
fidence interval in ICC (lower and upper bound of 0.39 and 0.98, respectively) was
observed for LRNC area measurements (Table 2.7).
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Table 2.6: Intra-rater reliability of radiologists in image interpretation at two different occa-
sions.
Parameters ICC Radiologist-1 ICC Radiologist-2 p value
Fibrous cap
thickness
0.95(0.86, 0.98) 0.91(0.76, 0.96) <.001
Fibrous cap
area
0.92(0.79, 0.97) 0.84(0.54, 0.94) <.001
Lipid rich necrotic
core area
0.96(0.89, 0.99) 0.96(0.88, 0.99) <.001
Note: Data in parentheses are 95% confidence intervals.
ICC = Intraclass Correlation Coefficient





Fibrous cap thickness 0.91(0.78, 0.96) <.001
Fibrous cap area 0.86(0.63, 0.95) <.001
Lipid rich necrotic core area 0.92(0.39, 0.98) <.001
Note: Data in parentheses are 95% confidence intervals.
ICC = Intraclass Correlation Coefficient
2.8 Discussion
In this study, we found that there was no significant difference between MARS SPCCT
and histopathological measurements of FC thickness, FC area, and LRNC area. Sim-
ilarly, the correlation between MARS measurements and histopathological findings
were excellent while measuring FC thickness and LRNC area. In addition, the limit of
agreement between MARS SPCCT and histopathology was comparatively higher while
measuring LRNC than FC thickness and FC area. The degree of agreement between
MARS SPCCT and histopathological measurements were better while measuring the
larger necrotic core. This can be explained by the fact that the necrotic core areas
were delineated subjectively by radiologists. Thus, it is suggested that the evaluating
radiologists were less accurate while measuring smaller LRNC areas.
Excellent intra- and inter-rater reliability among two radiologists (ICC of 0.9 and 0.8)
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may be explained by the fact that the measurements were obtained from ex-vivo sam-
ples. The ex-vivo samples had no surrounding soft tissue to obscure the vascular wall,
which in turn enabled the evaluating radiologists to precisely and reproducibly measure
those parameters. Notably, our ability to reproduce the same results in-vivo without
using intravascular contrast material in the future would primarily depend on the effec-
tiveness of SPCCT in differentiating vascular wall from adjacent soft tissue in a living
patient.
In 2012, Zainon et.al Zainon et al. (2012) showed the ability of MARS SPCCT in the
identification of different morphological components of atherosclerotic plaque, including
fibrous tissue and lipid-rich tissue, using material decomposition (MD) by converting
energy information to material information Bateman et al. (2018). We also used MD
images to classify atherosclerotic plaques (Figures 2.13, 2.14, 2.15, 2.16.) based on their
morphological features Stary et al. (1995). However, for quantitative measurement of
plaque components, only the attenuation characteristics of tissue were considered.
Among all existing non-invasive imaging modalities, MRI is best in identifying and
quantifying FC and LRNC regions of the atherosclerotic plaque Saba et al. (2019). Vari-
ous studies have shown a very good correlation (r=0.8) between MR and histopathology
Cai et al. (2005) while evaluating both intact fibrous cap (Cohen’s Kappa 0.74) or rup-
tured fibrous cap (Cohen’s Kappa 0.85) Den Hartog et al. (2013)). Similarly, MRI is ca-
pable of identifying LRNC with excellent reliability (ICC = 0.95). Contrast-enhanced
T1-weighted sequence has been shown to improve the delineation of atherosclerotic
components. However, there remains no consensus regarding an appropriate MRI set-
ting which could enable regular clinical use for imaging of plaques Den Hartog et al.
(2013).
Contrary to MRI, CT is not an appropriate modality for the evaluation of FC Saba
et al. (2019). Our study also found a weak limit of agreement between FC (both thick-
ness and area) measured by MARS SPCCT and histopathology. Nevertheless, in this
study, we noticed no significant difference between MARS SPCCT and histopatholog-
ical measurements of FC area and its thickness. A conventional CT also misidentifies
intra-plaque haemorrhage as fibrous tissue or LRNC Saba et al. (2019). In our study, we
did not compare haemorrhagic plaque, to exclude the confounding effect the hematoma
might have while measuring the plaque components.
However, the principal difference between ours and the above mentioned research was
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the ex-vivo nature of our study. Even though excised specimens were handled cor-
rectly, possible degradation of tissue at the cellular level in the excised samples could
not be ruled out. The effects of degraded tissue on the attenuation is not completely
known. Likewise, we used histopathology as the reference standard of measurement.
However, tissue shrinkage during histopathological examination made the comparison
of the absolute values more difficult. Similarly, the discrepancy in tissue thickness
between histopathological (4 µm) and MARS SPCCT images (90 µm) made the com-
parison less accurate. Finally, our study with relatively small sample size, where we
evaluated 13 plaques for LRNC and 18 plaques for FC, might not be sufficient to draw
an unambiguous conclusion. Thus, in-vivo prospective clinical trials or longitudinal
serial studies are required for unequivocal evidence that will support the incorporation
of MARS SPCCT as a regular clinical practice for plaque imaging in the future.
2.9 Conclusion
In this cross-sectional study, measurements of atherosclerotic components by MARS
SPCCT showed no significant difference from histopathological measurements. The
result demonstrated a viable technique for quantifying plaque composition due to the
combined effect of high spatial and energy resolution of MARS SPCCT.
2.10 Summary of the chapter
Atherosclerotic plaques become vulnerable to rupture with an increasing burden of
necrosis and with decreasing thickness of the fibrous cap. This study aimed to demon-
strate the effectiveness of MARS SPCCT in quantifying plaque composition, fibrous
cap (FC) thickness, FC area and lipid rich necrotic core (LRNC) area, in excised carotid
atherosclerotic plaques by comparing it with histopathological measurements.
Excised plaques of 20 patients (71 +/- 6 years; 13 men), obtained from carotid en-
darterectomy, were scanned with SPCCT using standardized acquisition settings. FC
thickness, FC area, and LRNC area were quantified by 3D multi-energy CT and
histopathology. Measurements by two modalities were compared usingWilcoxon signed-
rank test and Bland–Altman analysis.The multi-energy CT images were interpreted by
two radiologists, blinded to the histopathology, to measure FC thickness, FC area and
LRNC; inter- and intra-rater reliability were assessed with the intra-class correlation
coefficients (ICC).
Wilcoxon signed-rank test of histopathological and MARS SPCCT measurements of
FC thickness and FC area by two radiologists, consistently showed statistically non-
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significant p-values (>0.05). For LRNC, Wilcoxon signed-rank test was statistically
non-significant in all occasions except one. MARS SPCCT measurements strongly cor-
related with histopathology while measuring FC thickness and LRNC area with Kendall
tau coefficient consistently above 0.5. On other hand, correlation was weak while mea-
suring FC area (Kendall tau consistently <0.5). Bland-Altman analysis showed mean
difference and 95% confidence interval for FC thickness, FC area and LRNC area,
0.04 (-0.03 to +0.12) square root mm, -0.18 (-0.34 to -0.02) log10mm2 and 0.009 (-0.08
to+0.10) log10mm2 respectively. Inter- and intra- reader reliability between radiolo-
gists for FC thickness, LRNC (ICC=0.9/reader) and for FC area (ICC=0.8/reader)
were excellent.






Intraplaque haemorrhage is responsible for plaque vulnerability and subsequent inci-
dence of stroke Kolodgie et al. (2003), Michel et al. (2012), Alkhalil and Choudhury
(2020). Prevalence of intraplaque haemorrhage in symptomatic patients ranges from
7.4%- 91.3% in ex-vivo histopathological examination of Carotid endarterectomy or
cadaveric tissue Teng et al. (2014). This wide range of intraplaque bleeding in symp-
tomatic patients suggests multifactorial nature of atherosclerotic disease where haem-
orrhage alone can not be deterministic of plaque vulnerability. Nevertheless, the role
of intraplaque haemorrhage in transforming stable plaque to vulnerable plaque is well
established and non-ambiguous Chistiakov et al. (2015) .
Pathophysiologically, with increasing size, demand for oxygen rises in atherosclerotic
plaque. To overcome local hypoxia, a compensatory mechanism of neovascularization
from vasovasorum develops Virmani et al. (2005). These newly formed single cell en-
dothelial vessels are leaky and fragile to rupture causing extravasation of red blood cells
into the extravascular space where they can not survive for a long time Jeziorska and
Woolley (1999). Cell membranes of these dying erythrocytes contain large quantity of
free cholesterol, which causes rapid growth of lipid rich necrotic core inside the plaque
Yeagle (1985), Bloch (1991), Virmani et al. (2005). Furthermore, these erythrocytes
also contain proteolytic enzyme responsible for thinning of fibrous cap, subsequently
making plaque vulnerable to rupture Michel et al. (2012).
In the early 19th century, Paterson et al. first explained how intraplaque bleeding
caused by neovascularization could make plaque vulnerable to rupture Paterson (1936).
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Thereafter, multiple studies supported this theory which was well summarized by Gao
in 2007 Gao et al. (2007). Even though the role of intraplaque haemorrhage in plaque
vulnerability is well established, it has not been incorporated into the clinical criteria for
risk stratification of the disease because existing imaging modalities are not efficient
enough to effectively identify scanty amount of blood present in the atherosclerotic
plaque.
Among existing imaging modalities, contrast enhanced ultrasonography has shown
promising results in various feasibility studies in identifying intraplaque neovascular-
ization Vicenzini et al. (2007), Coli et al. (2008), Jain et al. (2020). Unfortunately, this
method is still in its infancy to be incorporated in the clinical practice.
Similarly, computed tomography and CT angiography, extensively used in Cerebral
Vascular Accidents (CVA), have major limitations due to exposure of ionising radia-
tion and artefacts associated with calcification/metal implants, which are frequently
present in the carotid artery. Moreover, conventional CT has poor soft tissue differen-
tiating ability to precisely identify intraplaque haematoma U-King-Im et al. (2010).
On other hand, studies have shown high sensitivity and moderate specificity of MRI
in identification of intrapalque haemorrhage Chu et al. (2004), Kassem et al. (2020).
However, presence of calcification and implants (stents) make it clinically unsuitable
to diagnose intraplaque haemorrhage in day to day clinical practice.
Against the backdrop of these difficulties in existing modalities, SPCCT brings re-
newed hope, as early study showed that MARS imaging is capable of identifying iron
in intraplaque hemorrhage with high degree of certainty Searle et al. (2018).
This qualitative study further explores the ability of the MARS scanner in identifying
iron in atherosclerotic plaque by validating findings with histopathological reference
standard.
3.2 Significance
Currently, haematomas are diagnosed in CT images based on attenuation character of
protein in the blood clot.Thus, there is a wide range of variability in Hounsfield values
of haematomas depending upon the age of blood clot. In this study we will find out
effectiveness of MARS SPCCT to identify intraplaque haematoma based on material
decomposition and not on Hounsfield values.
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Previously, in our group, we were able to differentiate iron from calcium in phan-
tom studies. Thereafter, same finding was replicated in biological samples. However,
histopathological validation of the result was not sought. This study reevaluates find-
ings, compares them with histopathological reference standard, and produces stronger
evidence.
3.3 Contribution
Study design, MARS scanning, image processing, histopathological slides preparation,
microscopy, data analysis and interpretation were done by me.
3.4 Objective
To find out effectiveness of MARS SPCCT in intraplaque hemorrhage.
3.5 Methodology
3.5.1 Study design
The study was approved by the Southern Regional Health and Disability Ethics Com-
mittee with approval number (CTY/01/04/036). All patients participating in this
study gave written informed consent to participate.
Twenty excised carotid arteries with atherosclerotic plaques were randomly selected
from the pool of stored specimens.They were scanned with MARS scanner then histopatho-
logical slides were prepared. Mars images were compared with histopathological refer-
ence standard.
3.5.2 Imaging
As described earlier, the imaging was performed using a small bore MARS scanner.
Scanning protocol was specifically optimized for plaque imaging; 118 kVp/19µA and
720 projections @100ms exposure time. Five energy thresholds with an integrated
charge-summing mode were set at 7, 18, 30, 45 and 75 keV resulting in five energy
channels (7–18, 18–30, 30–45, 45–75 and 75–118 keV). Calibration phantoms with mul-
tiple concentrations of ferric nitrate and hydroxyapatite along with lipid and water were
scanned to find the optimal linear relationship between different hydroxyapatite/ferric
nitrate concentrations and the output signal in hounsfield unit, forming a calibration
curve(Figure 3.1).
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Figure 3.1: a. Calibration phantom vials consisting of different concentrations of hydrox-
yapetite (HA) and ferric nitrate along with water and lipid b. Calibration curve.
Figure 3.2: Misidentification chart. Y axis= Percentage identification. X axis: HA= Hydrox-
yapetite of different concentrations FN= Ferric Nitrate of different concentrations
Misidentification chart was created to find out the effectiveness of MARS imaging
in differentiating of iron from HA, lipid and water. As shown in Figure 3.2, MARS
imaging effectively distinguished Iron in its higher concentration (Ferric nitrate 100%,
50% and 25%). However, in lower concentration (ferric nitrate 6.5%) misidentification
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of Iron was significant with HA, lipid and water.
3.5.3 Histopathology
Specimens were fixed with 9% formalin for 72 hours. They were then decalcified in
weak formic acid for 2 days. Thereafter, samples were neutralised with lithium carbon-
ate solution for 2 hours. Specimens were then embedded in paraffin and longitudinally
cut into 4 µm slices at every 5 mm interval (Figure 3.3). They were de-paraffinised
with xylene solution and washed with absolute alcohol. Descending concentrations of
ethanol were used to re-hydrate specimens. After that, they were stained in Prussian
blue solution with Eosin counterstain (Appendix A). Slides were dehydrated with as-
cending concentrations of alcohol and washed with xylene. Finally, they were mounted
with cover slips.
Potassium ferrocyanide (Perl’s solution) in acidic environment reacts with ferric com-
ponents of the blood (hemosiderin) and form blue ferric ferrocyanide (Persian blue).
Chemical equation is shown in Figure 3.4.
3.5.4 MARS histopathology comparison
For comparison, material decomposed MARS images were used. MARS and histology
images were visually matched with each other for comparison. Landmarks like distance
from carotid bifurcation, prominent area of calcification and /or luminal shape were
used to find regions of interest at identical histopathological and SPCCT images.
3.6 Observation and results
20 excised atherosclerotic plaques were evaluated. Demographic characteristics and
clinical history of patients are presented in the (Table 3.1). Out of 20 patients, 13 were
male.7 patients were >80 years and others were between 60 to 80 years. Overall, 11
patients were hypertensive, 4 were smokers and 3 were suffering from diabetic mellitus.
All 20 patients were on antilipidemic treatment. 8 were admitted with stroke, 6 with
Transient ischemic attack (TIA), 3 patients had Amaurosis fugax, and one patient had
more than one diagnosis. On Doppler ultrasonography, occlusions were distributed
between left and right internal carotid arteries almost equally (left = 9). One patient
had severe occlusion in the right Common Carotid Artery (CCA). 13 patients had
severe luminal occlusion (70-99%), while 7 patients had moderate luminal stenosis of
< 70% (Grant et al. (2003).
59
Chapter 3. Intraplaque haemorrhage


















































Age Y is presented as mean +- standard deviation
Numbers in parenthesis as percentage
IQR = Interquartile range
Out of 20 atherosclerotic plaques, MARS imaging showed iron signal in two plaques
(Table 3.2).
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On Perl’s Prussian blue stain, hemosiderins were seen in both of these plaques (Figure
3.3 and 3.4). Both of them were of patients who had acute stroke and had been on
antihypertensive drug.
Figure 3.3: Hemorrhagic plaque. a. Plaque specimen b. MARS 3D image c. MARS MD
image showing calcium (in white) and iron (in blue) d. Prussian blue stained 4 µmm slice-
pointer showing hemorrhagic region in the plaque.
Figure 3.4: Intraplaque micro haemorrhage- histopathological correlation. A: Chemical re-
action of Prussian blue formation. B: MARS image. C: MARS magnified MD image shows
region with iron signal D: Histopathological images of different magnification showing aggre-
gation of Iron containing macrophages.
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Table 3.2: Hemorrhagic plaques in MARS SPCCT and histopathology.
Total No. of specimens (n)




20 2 (10%) 2 (10%)
3.7 Discussion
In this study, both MARS SPCCT and histopathology showed iron in two specimens,
out of 20 evaluated (Table 3.2). It demonstrates that MARS SPCCT has an ability to
identify intraplaque iron.
Currently, MRI is considered as the imaging modality of choice for evaluation of in-
traplaque hemorrhage (IPH) Yuan et al. (2001), Altaf et al. (2008), Kassem et al.
(2020). It is a noninvasive tool which can potentially characterize tissue at the molec-
ular level Toussaint et al. (1996). Moreover, in MRI, components of atherosclerotic
plaque can be analyzed quantitatively with excellent reproducibility. In 2005, role
of intraplaque haemorrhage in progression of human atherosclerosis was studied in a
prospective study by Takaya et al. using high-resolution MRI Takaya et al. (2005).
That study in which MRI results were validated with histopathological reference stan-
dard showed overall accuracy (95% CI) of multispectral MRI 87% (80% to 94%), sen-
sitivity 85% (78% to 92%), and specificity 92% (86% to 98%). There was also good
agreement between MRI and histological findings (Cohen kappa (κ) = 0.69). Even
though sample size of 18 atherosclerotic plaques were perhaps not significant enough
to draw an unequivocal conclusions about effectiveness of MRI in plaque imaging, to its
credit, that was a prospective and in-vivo quantitative study which showed potential
of MRI in the vascular pathology.
Since carotid arteries are frequently imaged by computed tomography for better eval-
uation of the degree of luminal stenosis, there were multiple attempts to characterize
intraplaque haemorrhage in CT images Anzidei et al. (2012) Lell et al. (2007). One
notable study was conducted by Saba et al., where they reviewed CT images of 91
patients and assessed CT characteristics of the intraplaque haemorrhage comparing
them with histopathological slides Saba et al. (2018). They concluded that CT can be
used to identify the presence of intraplaque hemorrhage according to its attenuation
character and found that the threshold of 25 HU after the administration of contrast
medium was associated with high sensitivity and specificity (93.22% and 92.73%, re-
spectively) for intraplaque haemorrhage.
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Contrary to that study, in our study we used material decomposition for identifica-
tion of intraplaque iron. Although we found 100% agreement between MARS SPCCT
and histopathology in identifying intraplaque haemorrhage, relatively small sample size
with only two positive cases might not be enough to draw any definitive conclusion.
Furthermore our study was ex-vivo in nature and its effectiveness in live human being
is still needed to be explored. Nevertheless, this proof of concept study reconfirm pre-
vious findings about the ability of MARS technology in identifying iron as a marker
of intraplaque hemorrhage and pave way for more elaborative in-vivo studies in the
future Searle et al. (2018) .
3.8 Conclusion
The result shows that MARS imaging can identify and locate intra-plaque iron as a
sign of haemorrhage.
3.9 Summary of the chapter
A known morphology associated with plaque instability is the occurrence of intraplaque
haemorrhage where plaque rupture and remodelling results in the entrapment of red
blood cells within the plaque structure. The main aim of this qualitative study was to
find the effectiveness of MARS SPCCT in identification of iron, as a marker of intr-
plaque hemorrhage and validate it with histopathological reference standard. Twenty
human carotid plaque specimens obtained from surgery were imaged by MARS SPCCT
to identify regions rich in iron. Image confirmation was achieved by histological stain-
ing of tissue slices. The aggregation of hemosiderin as seen in microscopic images
correlate with the “iron signalling area”, which was identified in MARS imaging. Thus,
MARS imaging has the potential to enable clinicians to diagnose and treat unstable






Atherosclerosis is a disease in which plaque build up in the arterial wall becomes calci-
fied. Calcium deposits in the artery not only cause luminal narrowing but also indicate
an overall disease burden O’Rourke et al. (2000), Moradi et al. (2020), Sangiorgi et al.
(1998).
Quantification of calcium in cardiac arteries i.e. coronary calcium scoring, has been in-
corporated into standard clinical practice for risk stratification of myocardial infraction
for a long time Members et al. (2010), Cheong et al. (2020). Similarly, quantification of
abdominal aortic calcium in lateral lumber radiograph has been shown to be a reliable
independent predictor of vascular insufficiency Wilson et al. (2001). Likewise, a large
population-based cohort study found that aortic arch calcification was independently
related to the risk of coronary heart disease Iribarren et al. (2000).
Given the systemic nature of atherosclerotic disease, it can be assumed that the cal-
cium burden in carotid arteries must have similar effect in terms of luminal stenosis and
ischemic symptoms. Unfortunately, in spite of substantial available evidence, quantifi-
cation of carotid calcium has failed to get due attention from researchers and clinicians
due to the effectiveness of Doppler ultrasonography in characterizing luminal narrow-
ing, which is currently a sole criteria for assessing severity of the disease Culebras et al.
(1989), McKinney et al. (2005), Nandalur et al. (2006), Taoka et al. (2006), Sarikaya
et al. (2012), Perea Gabriel et al. (2020). However, with growing interest in intrinsic
characteristics of the plaque (Chapter 1), quantification of intraplaque calcification has
re-emerged as a potential bio-marker for determination of plaque burden, and therefore
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its vulnerability to rupture.
Computed tomography is the imaging modality of choice currently available for as-
sessing vascular calcification while being highly accurate in measuring luminal stenosis
Schwartz et al. (1992), Marks et al. (1993), Cumming and Morrow (1994), Cinat et al.
(1998), Marcus et al. (1999), Randoux et al. (2001). However, perceived measurements
of calcium in CT appears to be dependent on the energy of X-ray photon Wise et al.
(1997), Wiser and Adler (2001), Elbakri and Fessler (2002), Rodríguez-Granillo et al.
(2010).
A study with the dual energy CT has shown that accurate measurement of calcium
can be achieved at an energy range of about 80 keV Mannelli et al. (2013), significantly
lower than that of the conventional CT which uses high energy polychromatic X-ray
beam of about 120 keV for vascular imaging. In clinical setting, apart from calcium
quantification, plaque imaging consists of evaluation of other parameters like fibrous
cap and lipid rich necrotic core. Thus, calibration of X-ray energy according to its
effectiveness on an individual component of the plaque is not feasible and might risk
multiple exposures to patients.
In this study, quantification of vascular calcification was evaluated with MARS SPCCT
which can generate images in series of energy spectrum with a single exposure to the
patient.
4.2 Significance
This study provides much needed information regarding the appropriate energy of X-
ray beam for precise quantification of vascular calcification. Multi-energy system of
MARS SPCCT potentially allows clinician to choose best images for diagnostic accu-
racy with lowest possible radiation dose to patients. The evidence produced in this
study has been directly contributing to the ongoing clinical trial.
For the broader scientific community, findings is yet another input on current state
of knowledge, with the use of a novel imaging tool, SPCCT.
4.3 Contribution
I contributed in this study with study design, MARS imaging, histopathological slides




This study was conducted with the null hypothesis that "there is no significant dif-
ference between MARS SPCCT and histopathological measurements while measuring
intra- plaque calcification".
4.5 Objective
To find an appropriate energy of X-ray beam for precise quantification of intraplaque
calcification and compared them with histopathological reference standard.
4.6 Methodology
4.6.1 Study design
This study was approved by the Southern Regional Health and Disability Ethics Com-
mittee with an approval number (CTY/01/04/036). All patients participating in this
study gave written informed consent to participate.
Ten excised carotid arteries with atherosclerotic plaques were randomly selected from
the pool of stored specimens at -80 degree Celsius. They were thawed at room temper-
ature and scanned with small bore spectral photon counting CT scanner. Thereafter,
histopathological slides were prepared.
Two consultant radiologists were asked to measure area of eighteen calcified regions (of
ten atherosclerotic plaques) in five different energy images and material decomposed
images, blind to each other and histopathology, in two different sittings. Measurements
were compared with histopathological reference standard.
To ensure the reproducibility of the study possible sources of biases were identified
and addressed.
1. Selection bias - this type of sampling error was addressed by simple randomiza-
tion.
2. Confirmation bias - as a Ph.D student, conformation bias was a real possibility.
To reduce it, two independent radiologists were assigned to identify and measure
plaque calcification.
3. Observer bias - to reduce this bias, radiologists were asked to measure area of
calcification blind to histopathological findings.
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4. Role of chance - The result could have been achieved by chance. To minimise this
type of error, evaluating radiologists were asked to measure area of calcification
in two separate sittings. All together, four sets of measurements were evaluated.
4.6.2 Imaging
Appropriate imaging acquisition protocol was set up: 118 kVp/19µA and 720 pro-
jections @ 100ms exposure time. Five energy thresholds with an integrated charge-
summing mode were set at 7, 18, 30, 45 and 75 keV resulting in five energy channels
(7–18, 18–30, 30–45, 45–75 and 75–118 keV). Image reconstruction was performed using
in-house developed iterative reconstruction algorithm Bateman et al. (2018) at 19µA
isotropic voxel size. The FOV was 52mm with an image matrix size of 62.7 x 62.7 mm.
Calibration phantoms consisting with multiple concentrations of hydroxyapatite, ferric
nitrates, along with lipid and water were scanned to find the optimal linear relationship
between different hydroxyapatite concentrations and the output signal in Hounsfield
Units, forming a calibration curve. Thereafter, excised human atherosclerotic plaques
were scanned and material decomposition was applied on the imaging data (Figure
4.2).
4.6.3 Histopathological slides preparation
Specimens were fixed with 9% formalin for 72 hours. They were then decalcified in
weak formic acid for 2 days. Thereafter, samples were neutralised with lithium carbon-
ate solution for 2 hours. Specimens were then embedded in paraffin and longitudinally
cut into 4 µm slices at every 5 mm interval. They were de-paraffinised with xylene
and washed with absolute alcohol. Descending concentrations of ethanol were used to
re-hydrate specimens. Thereafter, they were stained with Haematoxylin & Eosin and
Alzarin red stains. Alzarin red is calcium specific PH sensitive staining protocol. Thus,
strict PH of 4.3 was maintained during the procedure (Appendix A).
Slides were then dehydrated with ascending concentrations of alcohol and washed with
xylene. Finally, they were mounted with cover slips.
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4.6.4 Comparison of SPCCT and histopathological images
Figure 4.1: Area of calcium in different keV images (a-e). Area of calcium in hydroxyapatite
MD image (f). Photographic image of carotid sample (g). H& E satin 4 µm thin x5 magnified
histopathological image (h)
Two consultant radiologists with experience in vascular imaging independently mea-
sured 18 calcified regions on the sagittal slices of five MARS SPCCT energy images (7
-18, 18 - 30, 30 - 45, 45 - 75 and 75 - 118 keV) and material decomposed (MD) images
of all 10 plaque specimens in two separate sittings.
Landmarks like distance from carotid bifurcation and luminal shape were used to find
regions of interest at identical MARS SPCCT and histopthological images. Figures
4.2 and 4.1, show comparison of different MARS SPCCT with histopathological im-
ages.
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Figure 4.2: Area of calcium in different keV images (a - e). Area of calcium in hydroxyapatite
MD image (f). Photographic image of carotid sample (g). Alzarin red satin 4 µm thin x5
magnified histopathological image (h)
4.6.5 Data analysis
Skewed distributions of data sets were normalized using log transformation. Two tailed
p value was set up at .05 for statistical significance with 95% confidence interval.
The research hypothesis was tested with Student t-test. Correlations were calculated
with Pearson’s correlation coefficients and limit of agreement between MARS SPCCT
and histopathology were presented in Bland–Altman plots. Linear regression between
mean measurements and differences values were done to find presence or absence of
proportional biases in Bland-Altman plots. Inter and intra-observer reliability of two
evaluating radiologists were tested with Intraclass Correlation Coefficient (ICC).
4.7 Observation and results
Student’s t-test showed nonsignificant difference between MARS imaging and histopathol-
ogy while measuring area of intraplaque calcification at 45-75 keV (p = >.05), 75-118
keV (p= >.05) and Material decomposition images (p= >.05). However, differences
were significant at 7-18 keV (p = >.05), 18-30 keV (p = >.05) and 30-45 keV (p =
>.05) images (Table 4.10).
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Table 4.1: Measurement of area of calcium in MARS imaging at different energy bins by
radiologist 1.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 2.30 2.70 2.00 1.89 1.53 1.50
2 3.00 3.00 3.10 2.80 2.60 1.28
3 .25 .28 .20 .27 .25 .20
4 7.30 8.00 8.00 6.80 6.50 3.90
5 58.00 60.00 64.00 32.00 22.00 22.00
6 10.20 11.40 9.11 6.50 5.10 4.80
7 1.53 1.36 1.39 1.11 .60 .50
8 4.30 4.80 4.60 3.80 3.50 2.80
9 7.30 8.00 8.00 6.80 6.50 5.90
10 1.20 1.20 1.20 .79 .56 .59
11 .62 .51 .35 .34 .39 .49
12 5.70 5.70 5.10 4.80 4.30 3.60
13 4.70 5.90 4.70 3.00 2.80 3.90
14 4.70 5.90 4.70 3.00 2.80 2.20
15 2.30 2.40 2.20 1.70 1.60 1.80
16 3.70 3.90 3.50 3.30 2.10 2.30
17 9.70 10.50 8.10 8.60 9.60 8.00
18 .55 .44 .37 .19 .27 .40
19 3.70 4.30 3.00 2.70 2.70 3.00
20 .94 1.00 .80 .72 .69 .79
Note: MD = Material decomposition. Values are in mm2.
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Table 4.2: Re- evaluation of area of calcium in MARS imaging at different energy bins by
radiologist 1.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 2.00 1.23 2.10 1.65 1.80 1.60
2 3.00 3.30 2.91 2.40 1.28 1.00
3 .25 .25 .15 .23 .18 .22
4 9.40 9.10 7.80 6.40 6.20 5.10
5 60.00 60.00 48.00 36.00 33.00 27.00
6 10.00 9.10 8.00 7.20 7.50 4.90
7 1.20 1.20 1.90 .92 .50 .56
8 4.50 4.00 4.30 3.20 3.00 2.50
9 8.90 8.10 6.80 5.20 5.90 6.00
10 1.10 1.10 .90 .50 .46 .45
11 .68 .59 .38 .41 .30 .47
12 5.70 4.90 3.40 3.00 3.30 3.90
13 3.40 4.60 4.80 3.10 3.20 4.90
14 5.00 4.80 5.10 4.30 4.70 .88
15 2.50 2.40 2.20 4.00 3.20 2.50
16 3.90 3.20 2.00 1.97 1.79 1.50
17 10.00 8.90 9.00 8.90 9.00 9.00
18 .57 .39 .39 .33 .32 .50
19 3.30 3.20 3.00 3.80 3.60 3.00
20 .88 .93 1.00 .86 .79 .79
Note: MD = Material decomposition. Values are in mm2.
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Table 4.3: Measurement of area of calcium in MARS imaging at different energy bins by
radiologist 2.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 2.98 2.56 1.99 2.00 1.50 1.59
2 3.80 3.70 3.64 3.90 1.28 1.10
3 .30 .30 .28 .20 .22 .24
4 9.40 9.50 9.10 8.40 8.20 7.10
5 58.00 60.00 67.00 34.00 33.00 33.00
6 12.00 12.90 6.70 7.00 5.80 5.10
7 1.20 .92 .99 1.00 .80 .58
8 5.00 4.30 4.60 3.20 2.80 1.90
9 9.00 8.70 8.70 6.80 6.00 6.30
10 1.00 1.10 .89 .75 .63 .43
11 .64 .59 .54 .48 .30 .41
12 5.00 4.40 3.60 3.40 2.90 3.10
13 3.90 5.00 4.20 4.10 3.50 4.80
14 5.20 5.00 4.70 3.00 3.00 2.90
15 3.90 2.80 2.70 1.90 1.40 1.20
14 4.80 4.80 3.90 3.80 2.80 2.00
17 10.40 9.90 8.80 8.90 8.00 8.50
18 .41 .40 .36 .30 .29 .23
19 3.40 3.00 2.30 1.23 1.33 2.00
20 .85 .85 .82 .79 .89 .80
Note: MD = Material decomposition. Values are in mm2.
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Table 4.4: Re- evaluation of area of calcium in MARS imaging at different energy bins by
radiologist 2.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 3.00 2.80 2.10 1.90 1.40 1.50
2 3.20 3.00 3.00 2.90 2.50 1.67
3 .30 .25 .25 .30 .28 .20
4 8.50 8.20 8.00 6.70 6.50 3.50
5 62.00 58.00 56.90 33.00 24.40 23.90
6 13.70 12.80 8.20 7.50 5.00 4.90
7 2.00 1.39 1.40 1.00 .60 .52
8 4.60 4.00 3.50 2.80 .60 .45
9 9.20 8.20 7.80 6.50 3.10 2.50
10 .95 1.50 1.00 .98 .40 3.50
11 .59 .49 .50 .40 .36 .28
12 4.80 4.50 4.30 3.40 3.00 2.10
13 4.00 3.10 3.00 2.50 3.00 3.60
14 5.10 4.90 3.80 2.90 2.61 2.60
15 2.80 2.10 1.80 1.50 3.70 3.60
14 5.00 3.00 2.50 1.60 1.80 1.40
17 10.10 9.90 8.70 6.40 6.80 2.80
18 .42 .37 .38 .36 .31 .39
19 3.70 3.40 2.50 2.60 1.80 .77
20 .91 .99 .87 .97 .85 .67
Note: MD = Material decomposition. Values are in mm2.
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Table 4.5: Log transferred data measured by radiologist 1.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 .36 .43 .30 .28 .18 .18
2 .48 .48 .49 .45 .41 .11
3 -.60 -.55 -.70 -.57 -.60 -.70
4 .86 .90 .90 .83 .81 .59
5 1.76 1.78 1.81 1.51 1.34 1.34
6 1.01 1.06 .96 .81 .71 .68
7 .18 .13 .14 .05 -.22 -.30
8 .63 .68 .66 .58 .54 .45
9 .86 .90 .90 .83 .81 .77
10 .08 .08 .08 -.10 -.25 -.23
11 -.21 -.29 -.46 -.47 -.41 -.31
12 .76 .76 .71 .68 .63 .56
13 .67 .77 .67 .48 .45 .59
14 .67 .77 .67 .48 .45 .34
15 .36 .38 .34 .23 .20 .26
14 .57 .59 .54 .52 .32 .36
17 .99 1.02 .91 .93 .98 .90
18 -.26 -.36 -.43 -.72 -.57 -.40
19 .57 .63 .48 .43 .43 .48
20 -.03 .00 -.10 -.14 -.16 -.10
Note: MD = Material decomposition. Values are in log10mm2.
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Table 4.6: Log transferred data re- evaluated by radiologist 1.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 .30 .09 .32 .22 .26 .20
2 .48 .52 .46 .38 .11 .00
3 -.60 -.60 -.82 -.64 -.74 -.66
4 .97 .96 .89 .81 .79 .71
5 1.78 1.78 1.68 1.56 1.52 1.43
6 1.00 .96 .90 .86 .88 .69
7 .08 .08 .28 -.04 -.30 -.25
8 .65 .60 .63 .51 .48 .40
9 .95 .91 .83 .72 .77 .78
10 .04 .04 -.05 -.30 -.34 -.35
11 -.17 -.23 -.42 -.39 -.52 -.33
12 .76 .69 .53 .48 .52 .59
13 .53 .66 .68 .49 .51 .69
14 .70 .68 .71 .63 .67 -.06
15 .40 .38 .34 .60 .51 .40
14 .59 .51 .30 .29 .25 .18
17 1.00 .95 .95 .95 .95 .95
18 -.24 -.41 -.41 -.48 -.49 -.30
19 .52 .51 .48 .58 .56 .48
20 -.06 -.03 .00 -.07 -.10 -.10
Note: MD = Material decomposition. Values are in log10mm2.
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Table 4.7: Log transferred data measurement by radiologist 2.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 .47 .41 .30 .30 .18 .20
2 .58 .57 .56 .59 .11 .04
3 -.52 -.52 -.55 -.70 -.66 -.62
4 .97 .98 .96 .92 .91 .85
5 1.76 1.78 1.83 1.53 1.52 1.52
6 1.08 1.11 .83 .85 .76 .71
7 .08 -.04 .00 .00 -.10 -.24
8 .70 .63 .66 .51 .45 .28
9 .95 .94 .94 .83 .78 .80
10 .00 .04 -.05 -.12 -.20 -.37
11 -.19 -.23 -.27 -.32 -.52 -.39
12 .70 .64 .56 .53 .46 .49
13 .59 .70 .62 .61 .54 .68
14 .72 .70 .67 .48 .48 .46
15 .59 .45 .43 .28 .15 .08
14 .68 .68 .59 .58 .45 .30
17 1.02 1.00 .94 .95 .90 .93
18 -.39 -.40 -.44 -.52 -.54 -.64
19 .53 .48 .36 .09 .12 .30
20 -.07 -.07 -.09 -.10 -.05 -.10
Note: MD = Material decomposition. Values are in log10mm2.
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Table 4.8: Log transferred data re- evaluated by radiologist 2.
Samples Energy bins7- 11 keV 11- 30 keV 30- 45 keV 45- 75 keV 75- 118 keV MD
1 .48 .45 .32 .28 .15 .18
2 .51 .48 .48 .46 .40 .22
3 -.52 -.60 -.60 -.52 -.55 -.70
4 .93 .91 .90 .83 .81 .54
5 1.79 1.76 1.76 1.52 1.39 1.38
6 1.14 1.11 .91 .88 .70 .69
7 .30 .14 .15 .00 -.22 -.28
8 .66 .60 .54 .45 -.22 -.35
9 .96 .91 .89 .81 .49 .40
10 -.02 .18 .00 -.01 -.40 .54
11 -.23 -.31 -.30 -.40 -.44 -.55
12 .68 .65 .63 .53 .48 .32
13 .60 .49 .48 .40 .48 .56
14 .71 .69 .58 .46 .42 .41
15 .45 .32 .26 .18 .57 .56
14 .70 .48 .40 .20 .26 .15
17 1.00 1.00 .94 .81 .83 .45
18 -.38 -.43 -.42 -.44 -.51 -.41
19 .57 .53 .40 .41 .26 -.11
20 -.04 .00 -.06 -.01 -.07 -.17
Note: MD = Material decomposition. Values are in log10mm2.
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Table 4.9: Histopathological measurement of calcium and normalize data with log trasferma-
tion
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Table 4.10: Student’s t- test: Measurement of area of calcium in MARS imaging vs









7-18 p = <.001 p = <.001 p = <.001 p = <.001
18-30 p = <.001 P = <.001 p = <.001 p = <.001
30-45 p = .002 p = .005 p = .001 p = .004
45-75 p = .056 p = .062 p = .046 p = .099
75-118 p = .295 p = .304 p = .597 p = .717
MD p = .588 p = .823 p = .939 p = .382
Note: MD = Material Decomposition; p = p value.
There was strong correlation between SPCCT and histopathology for measurement of
calcifications in all energy bins (r = 0.9) and also in MD images (r = 0.9) (Table 4.11).
Table 4.11: Pearson’s correlation coefficient between different MARS images and histopathol-









7-18 r= 0.94 r= 0.93 r= 0.92 r= 0.92
18-30 r= 0.94 r= 0.93 r= 0.93 r= 0.92
30-45 r= 0.92 r= 0.92 r= 0.92 r= 0.92
45-75 r= 0.93 r = 0.91 r= 0.92 r= 0.91
75-118 r= 0.94 r= 0.93 r= 0.92 r= 0.86
MD r= 0.96 r= 0.92 r= 0.95 r= 0.75
Note: MD = Material Decomposition; r = Pearson’s correlation coefficient.
p = <.001.
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Figure 4.3: Bland Altman plot of calcium measurement. MARS 45 - 75 keV against
histopathology measurements.
Figure 4.4: Bland Altman plot of calcium measurement. MARS 75 - 118 keV against
histopathology measurements.
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Figure 4.5: Bland Altman plot of calcium measurement. MARS MD against histopathology
measurements.
Bland- Altman analysis showed mean difference and 95% confidence interval for area
of calcification in 45-75 keV, 75-118 keV and MD images against histopathological
measurements were , 0.92 ( -0.003 to +0.180) log10 mm2, 0.023(- 0.063 to + 0.11) log10
mm2 and 0.010 (- 0.0 to + 0.067) log10 mm2 respectively (Figures 4.3, 4.4, 4.5). No
proportional or fixed biases observed.
Table 4.12: Intra - rater reliability of radiologist while measuring calcium size at two different
occasions.
Energy Bins ICC (Radiologist - 1) ICC Radiologist - 2 p - value
7 - 18 keV 0.99 (0.99 - 0.99) 0.99 (0.98 - 0.99) <.001
18 - 30 keV 0.99 (0.96 - 0.99) 0.99 (0.98 - 0.99) <.001
30 - 45 keV 0.99 (0.98 - 0.99) 0.98 (0.98 - 0.99) <.001
45 - 75 keV 0.99 (0.95 - 0.99) 0.98 (0.95 - 0.99) <.001
75 - 118 keV 0.98 (0.95 - 0.99) 0.95 (0.89 - 0.98) <.001
Material images 0.98 (0.96 - 0.99) 0.88 (0.71 - 0.95) <.001
Note: Data in parentheses are 95% confidence interval.
ICC = Intraclass correlation coefficient.
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As shown in table, there was an excellent reliability between two radiologists for quan-
tification of intraplaque calcification in different MARS SPCCT images (ICC= 0.9)
(Table 4.12). Similarly both vascular radiologists had excellent reliability while mea-
suring intraplaque calcification on two different sittings (ICC= 0.9).
Table 4.13: Inter - rater reliability of two radiologists while measuring calcium size.
Energy Bins Intraclass correlation coefficient (ICC) p - value
7 - 18 keV 0.99 (0.99 - 0.99) <.001
18 - 30 keV 0.99 (0.96 - 0.99) <.001
30 - 45 keV 0.99 (0.98 - 0.99) <.001
45 - 75 keV 0.99 (0.95 - 0.99) <.001
75 - 118 keV 0.98 (0.95 - 0.99) <.001
Material images 0.98 (0.96 - 0.99) <.001
Note: Data in parentheses are 95% confidence interval.
4.8 Discussion
In this study, we observed that the correlation between MARS SPCCT and histopatho-
logical measurements of intraplaque calcium were excellent across all energies and ma-
terial decomposed (MD) images. In addition, there was no significant difference in
perceived size of intraplaque calcification between MARS SPCCT images at above 45
keV and histopathological reference standard. However, at lower energies X-rays below
45 keV, MARS SPCCT significantly overestimates the area of calcification.
Overestimation of size not only causes imprecision in quantification of calcium, but
also effect on evaluation of other morphological components, like fibrous cap thickness
and lipid rich necrotic core area of the plaque.
A study done in dual energy CT, where 200 calcified regions from five different excised
plaque specimen were compared with histopathological measurement, showed that area
of intraplaque calcium evaluated at 80 keV x-ray energy beams were most comparable
with the histopathological measurements Mannelli et al. (2013). That study also found
overestimation of calcium size at lower energy images. However, contrary to ours, that
was conducted on relatively small number of samples (five) even though regions of
interests were significantly higher (two hundred). In addition to that, in that study
no randomisation was done which led to the possibility of sampling error. Moreover,
CT slices were almost 10 times thicker than ours where they compared 1mm thick CT
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images with 4 µm histological slice.
The major limitation of both of these studies were their ex-vivo nature in which mi-
croscopic level of tissue degradation could not be ruled out during the experiment.
Furthermore, effect of surrounding soft tissue around pulsatile arteries should also be
considered while interpreting the imaging results in both of these studies.
Nevertheless, this study gave us valuable information regarding the most appropri-
ate energy of X-ray beam we should be using in carotid imaging of live human being
for quantification of calcium burden. Moreover, these findings have potential to repro-
duce in vascular pathology of other organs like heart and limbs in the future.
To ensure reproducibility, this study was properly designed and possible sources of
biases were identified. Appropriate actions, like sample randomization and blindness,
were performed to minimise those errors. Validation of the results were obtained by
comparing SPCCT images with histopathological reference standard.
The knowledge generated in this study has been applied on the imaging of stroke
patient (Chapter 6). Thus, this work is clinically relevant with traslational ability. To
my knowledge, this is the first attempt to quantify carotid calcium using SPCCT.
4.9 Conclusion
Material decomposition images and images of high energy bins are most appropriate
for quantification of intraplaque calcification because at lower energy ranges calcium
size gets overestimated.
4.10 Summary of the chapter
There is a positive correlation between calcium burden within plaques located at the
carotid bifurcation and the degree of stenosis. Therefore, quantification of plaque calci-
fication could play a key role in assessing patients for suitability of treatment modality,
its optimisation, and surgical planning. This study identified appropriate energy of
X-ray beam in MARS SPCCT for precise quantification of vascular calcification.
Ten excised carotid plaques were scanned, and eighteen calcified foci were analysed.
MARS energy and material images were compared with digitalised histopathological
images using Student’s t- test. Intraclass correlation coefficient (ICC) was calculated
to test the reliability of vascular radiologists who evaluated the images blind to the
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histopathological findings.
It was found that there was no significant difference between calcifications measured by
histology and those measured by MARS SPCCT at higher energies (>45 keV) and ma-
terial decomposed images (MD) (p = > 0.05). Lower energies overestimated calcium
measurements. Thus, vascular calcification could be more accurately characterized






Biological samples can be preserved in plastic permanently for educational and demon-
strative purpose. However, effect of plastic on identifying internal structures of bio-
logical sample with medical imaging has not been extensively studied yet. This study
explores suitability of plastinated cadaveric aortic samples for quantification of vulvu-
lar calcification using MARS SPCCT.
A large number of people after age of 65 years have various degree of calcification
in aortic valve which is a common incidental finding on cardiac imaging Lindroos et al.
(1993). While this does not necessarily progress into clinically significant disease within
most people’s lifetimes, calcium burden in the aortic valves has proved to be a major
contributing factor in aortic stenosis requiring valve replacement procedure Fletcher
et al. (2021). Nearly 300 people dies annually due to aortic valve stenosis in New
Zealand and total cost of valve replacement surgeries is around 30 million dollars an-
nually in the countryCommittee (2015).
Around 25% of people above 65 years develop aortic sclerosis whereas less than 5% of
people more than 75 years shows aortic calcification Lindroos et al. (1993). Thus, aortic
valve calcification is a disease of elderly which occurs in degenerative valve leaflets. His-
tological studies performed in the late 1990’s promoted the theory that atherosclerotic
plaques in the valve leaflets were responsible for the initiation of the calcific process.
Expression of bone morphogenic protein -2, 4 and development of osteoblastic cell
within the aortic valves show that it is an active process which includes atherosclerotic
and inflammatory components. However, large randomised trial in the 2000’s showed
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no benefit with the use of statin therapy Cowell et al. (2005) , although many criti-
cised this trial for initiating therapy too late in the disease process. Similarly another
trial by Rossebø, et al also demonstrated two lipid lowering agents, Simvastatin and
ezetimibe did not reduce the composite outcome of combined aortic-valve events and
ischemic events in patients with aortic stenosis Rossebø et al. (2008) . Thus, currently
valve replacement, usually with the minimal invasive therapy like intravascular valve
replacement without surgery, is the only treatment of choice for this disease.
Pathophysiologically, outflow obstruction due to aortic valve stenosis leads to left ven-
tricular hypertrophy. Diastolic dysfunction of left ventricle develops backflow pressure
leading to left atrial hypertrophy. It increases pulmonary wedge pressor manifesting
signs and symptoms of left heart failure. Besides cardiac failure, angina and syncope
are other two major sings of aortic valve stenosis. These clinical sings are prognos-
tically unfavourable and mortality is high in symptomatic patients. Horstkotte et al
found mean survival after sings and symptoms of left heart failure was 11±10 months
.After syncope. it was 27±15 months and was 45±13 months after angina Horstkotte
and Loogen (1988)
5.2 Significance of the study
Existing imaging modalities have various degree of effectiveness on identification and
quantification of internal structure of the specimen embedded in plastics. This study
explores usefulness of MARS SPCCT in characterising calcification of plastinated aortic
valves. Moreover, the amount of calcium deposition in the aortic valve determines
the severity of aortic stenosis. Thus, quantification of valvular calcification has great
clinical significance in risk assessment of the diseaseKoos et al. (2004).
5.3 Contributions
Plastinated cadaveric samples were provided by local collaborator. Scanning, image
interpretation, and data analysis were done by me.
5.4 Research hypothesis
This study was conducted with the null- hypothesis that there is no significant difference




The main objective of this study was to find an effectiveness of MARS SPCCT to
characterize aortic valve calcification in plastinated biological samples.
5.6 Methodology
5.6.1 Study design
Three plastic embedded cadaveric aortic valve samples were received for scanning. Area
of calcification were measured and compared with MARS measurement.
5.6.2 MARS imaging
Figure 5.1: a. Calibration phantom consisting of different concentration of HA , lipid and
water. b. MARS material decompose image,Blue = water, Yellow= Lipid and White=
Hydroxyapetite.
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Figure 5.2: Calibration curve of different concentration of Hydroxyapetite.
Calibration phantoms, HA50, HA100, HA400,HA400 and HA600 along with lipid and
water, were scanned to find the optimal linear relationship between different HA con-
centration and the output CT signal in Hounsfield Units (HU), forming a calibration
curve (Figures 5.1, 5.2).
The imaging was performed using a small bore MARS scanner (MARS-11 v5, MARS
Bioimaging Ltd., Christchurch, New Zealand) Raja et al. (2018). Specimens were
scanned individually with image acquisition protocol specifically optimized for valvu-
lar imaging; 120 kVp/36µA and 360 projections @100ms exposure time. Five energy
thresholds with an integrated charge-summing mode were set at 7, 18, 30, 45 and 75
keV resulting in five energy channels ( 18–30, 30–45, 45–75 and 75–120 keV). Image
reconstruction was performed using in-house developed iterative reconstruction algo-
rithm Bateman et al. (2018) at 90 µm isotropic voxel size. The FOV was 52mm with
an image matrix size of 62.7 x 62.7 mm.
Material decomposition was applied. Misidentification chart was developed to find
percentage misidentification of HA, lipid and water. As shown in Figure 5.3, differ-
ent hydroxyappetite concentrations were accurately identified by the scanner, however
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lipid and water were miss-identified.
Figure 5.3: Misidentification chart.Different concentration of HA, water and lipid on X- axis.
Percentage identification on Y axis.
5.6.3 Comparison between SPCCT and true measurement
Calcifications were identified on the MARS images and compared with true values.
Area of twenty calcified regions were measured in plastinated specimen and com-
pared with MARS measurements in five different spectral and material decomposes
images.
5.6.4 Data analysis
Skewed data sets were first normalized with log transformation. Two tailed p value
was set up at .05 for the statistical significance. Hypothesis was tested with non-
parametric Wilcoxon signed rank test. Bland- Altman plots were used to find the limit
of agreement between true value and MARS value of calcium measurements.
5.7 Observation and results
Mars material decomposed images and photographic images show different foci of cal-
cification in Figures 5.4 and 5.5. All calcific foci were well delineated in MARS material
decompose images. However, aortic contour and valves were not appreciable. 75-118
keV image also shows different foci of calcification 5.6
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Figure 5.4: Aortic valve calcification and MARS image. Upper row (a, b and c)) shows
plastinated cadaveric aortic specimens. Lower row (d, e and f) shows corresponding MARS
material decomposed images.
Figure 5.5: Identification of aortic valve calcification. A: Photographic image, B: Correspond-
ing MARS material decomposed image.
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Figure 5.6: Identification of aortic valve calcification. in 75-118 keV
Table 5.2: Wilcoxon test. Area of aortic valve calcification on MARS imaging vs true mea-
surement at different energy bins.
Energy bins Wilcoxon rank-sum test
7 - 18 keV p = <.001
18 - 30 keV p = <.001
30 - 45 keV p = <.001
45 - 75 keV p = <.001
75 - 118 keV p = .06
MD p = .16
Note: MD = Material Decomposition p = p value
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Table 5.1: Area of aortic calcification in MARS SPCCT and true value.
Samples Energy ranges (keV)
7- 11 11- 30 30- 45 45- 75 75- 118 MD Truemeasurement
1 4.10 4.07 4.00 3.40 4.00 3.20 3.10
2 3.40 3.40 3.10 2.80 2.40 2.40 2.20
3 3.70 3.60 3.40 2.80 2.60 2.40 2.40
4 3.40 3.40 3.10 2.45 1.90 2.10 1.90
5 2.70 2.80 2.60 2.00 1.70 1.60 1.50
6 4.00 3.90 3.90 2.90 2.80 2.90 2.80
7 .56 .54 .52 .43 .32 .35 .38
8 .19 .19 .18 .15 .13 .12 .12
9 1.90 1.89 1.78 1.67 .84 .82 .71
10 3.40 3.20 3.00 2.60 2.50 2.40 2.60
11 4.10 4.02 3.90 3.70 3.10 2.90 3.00
12 3.30 3.20 3.00 2.80 2.90 2.80 1.80
13 .68 .68 .67 .52 .48 .46 .45
14 1.80 1.77 1.67 1.20 .64 .62 .69
15 4.10 4.10 3.90 3.30 3.00 3.10 3.10
14 3.20 3.20 3.10 2.90 2.80 2.90 2.70
17 1.90 1.89 1.20 .90 .89 .87 .91
18 1.60 1.50 1.00 .92 .79 .72 .70
19 2.00 12.10 1.90 1.67 1.50 1.50 1.60
20 .38 .37 .34 .30 .24 .22 .20
Note: MD = Material decomposition. Values are in mm2.
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Figure 5.7: Bland Altman plot MARS 75 - 118 keV and true measurements.
Figure 5.8: Bland Altman plot MARS MD and true measurements.
Wilcoxon sign rank test showed statistically significant difference between MARS mea-
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surements and true measurements in lower energy images (7 - 18, 18 - 30 , 30 - 45 and,
45 - 75 keV) whereas in images of upper energy spectrum ( 75 - 118 keV) and material
images, it was statically not significant. Bland - Altman analysis showed mean differ-
ence and 95% confidence interval in 75 - 188 keV and material images 0.28 (-0.056 to
+ 0.00) log10mm2 and 0.15 (-0.08 to +0.039) log10mm2 respectively. Both 75- 118 keV
and MD showed 50% limit of agreement between histopathology findings and MARS
SPCCT images. No proportional or fixed biases observed.
5.8 Discussion
This study reconfirms the effectiveness of material decomposed images and images of 75
- 118 keV to quantify vascular calcification in aortic valve. It also shows that plastinated
samples are not appropriate for soft tissue characterization because attenuation of
plastic significantly hinders delineation of soft tissue components. Overall, this study
gives us an added insight on the ability of MARS SPCCT in characterizing vascular
calcification.
5.9 Conclusion
This study shows that plastinated biological samples are not appropriate for soft tissue
imaging and lower energy spectrum of X-ray beams overestimate calcium size.
5.10 Summary of the chapter
Biological samples are embedded in plastics for long term preservation. This study tried
to explore the effectiveness of MARS SPCCT in characterizing calcification in plasti-
nated biological specimens. Aortic valves were chosen because calcific aortic valve is
the most common incidental findings in chest X-ray and found to have contributed in
cardiovascular disease.
This preclinical study began with scanning a calibration phantom using the MARS
spectral scanner to find the optimal linear relationship between different hydroxyap-
atite concentrations and the output CT signal, forming a calibration curve. Cadaveric
aortic valve samples were scanned and analysed using the MARS SPCCT.
Wilcoxon sign rank test showed statistically significant difference between MARS mea-
surements and true measurements in lower energy images (7 - 18, 18 - 30 , 30 - 45 and,
45 - 75 keV) whereas in images of upper energy spectrum ( 75 - 118 keV) and material
images, it was statically not significant.
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Bland - Altman analysis showed mean difference and 95% confidence interval in 75
- 188 keV and material images 0.28 (-0.056 to + 0.00) log10mm2 and 0.15 (-0.08 to
+0.039) log10mm2 respectively.
This study reconfirm effectiveness of high energy X-ray beam and material decom-






As stated earlier, the main aim of MARS project is to bring SPCCT to clinics. Evidence
we generated in pre-clinical experiments described earlier were directly applied on
acquisition and interpretation of human images as illustrated in this chapter. On
20/10/2020, we successfully scanned first patient with carotid atherosclerotic disease.
This transition from preclinical experiments with small bore lab scanner to human
imaging using clinical type machine was a significant technological breakthrough.
6.2 Significance
The main aim of studies described in this chapter is to demonstrate the traslational
ability of MARS SPCCT from preclinical research to human imaging.
6.3 Contribution
Sample preparation of both sheep’s heart and lamb’s knee were done by me and co-
worker Emily Searle. Similarly, both of us had equal contribution to scanning, image
processing and interpretation of those images.
During patient’s knee and neck imaging wider group of MARS team consisting of
physicists, bio-technologists, radiographers and clinical researchers were involved. My
contributions in those studies included protocol optimization, scanning of patients,
image processing and interpretation of acquired images.
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6.4 Equipment
A large bore, 70 mm diameter MARS SPCCT scanner which uses the same spectral
CT technology platform for the acquisition of spectral CT data, image reconstruction,
material decomposition and visualisation as used on small-bore MARS photon-counting
CT was used.(Chapter1)
6.5 Preparation
Before putting patient into the scanner, we performed two short preparatory experi-
ments to ensure readiness of the system.
1. First scan was of excised human carotid artery embedded in the lamb’s knee to
find effect of surrounding soft tissue on identification of vascular wall.
2. Second was a scan to identify effectiveness of MARS scanner in scanning large
soft tissue. We scanned excised sheep’s heart for this purpose.
Plaque specific imaging protocol was set-up in MARS prototype human scanner (MARS
14); 118 kVp/19µA and 720 projections @ 140ms exposure time (Table 6.1). Five energy
thresholds with an integrated charge-summing mode were set at 7, 35, 50, 62 and 75
keV resulting in five energy channels (7–35, 35–50, 50–62, 62–75 and 75–120 keV).
Image reconstruction was performed using in-house developed iterative reconstruction
algorithm Bateman et al. (2018) at 90µm isotropic voxel size. The FOV was 120 mm
with an image matrix size of 62.7 x 62.7 mm.
Table 6.1: Imaging protocol.
Parameters Values
Tube voltage 118 kVp
Tube current 19µA
Exposure time 140 ms
FOV 120 mm
Filtration 2 mm Aluminium
Voxel size 90µ m
Energy Thresholds 7 - 35, 35 - 50, 50 - 62, 62 - 75, 75 - 120 keV
Appropriate sample holders were prepared for each of these specimens (excised lamb
knee and sheep heart).
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6.5.1 MARS imaging of excised human carotid atherosclerotic
plaque embedded inside lamb’s popliteal fossa
Introduction
This was a feasibility study in which in-vivo environment was simulated by inserting
excised carotid artery inside lamb’s popliteal fossa.
Objectives
To find effectiveness of MARS images in identification of human carotid artery from
surrounding soft tissue and evaluate different structure of atherosclerotic plaque.
Methodology
Figure 6.1: Lamb’s Knee sample preparation. a. Excised human carotid artery. b. Insertion
of human carotid artery inside lamb’s popliteal fossa. c. Fixation of artery inside popliteal
fossa.
Figure 6.2: a. Calibration phantom. b. Spectral response.
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Calibration phantoms,with different concentrations of hydroxyapatite along with lipid
and water, were scanned to find the optimal linear relationship between different HA
concentration and the output CT signal in Hounsfield Units (HU), forming a calibra-
tion curve (Figure 6.2).
Frozen human carotid artery was thawed at room temperature. A fresh lamb’s knee
was bluntly dissected and the specimen was placed inside popliteal fossa of lamb knee
(Figures 6.1). The specimen was scanned with carotid artery completely sutured inside
the popliteal fossa.Material decomposition images were created for evaluation, (Figure
6.3)).
Findings
Arterial wall of inserted carotid artery could not be delineated. However, spotty calci-
fication of carotid plaque were visualized (Figure 6.3).





Non calcified arterial wall is difficult to visualise in MARS images.
Even though we tried to mimic in-vivo scenario, inserted artery was compressed by the
surrounding soft tissue without anticipated fat pad around the artery. We hoped,that
in live human being, thin fat layer which surrounds the artery allows us to delineate
arterial wall from surrounding soft tissue..
6.5.2 MARS imaging of excised sheep heart
Introduction
This was another preparatory study to ensure readiness of scanner to scan the human
neck. As mentioned earlier, heart was chosen because of its large size. Moreover, it
is complex organ with different structures and tissue. Fresh sheep’s heart was used to
avoid microscopic tissue degradation that might be present in old specimen.
Objectives
To explore the ability of MARS scanner in scanning large complex large organ like
sheep heart.
Methodology
Different concentration of calibration phantoms along with lipid and water, were scanned
to find the optimal linear relationship between different HA concentration and the out-
put CT signal in Hounsfield Units (HU), forming a calibration curve (Figure 6.2). In
build material decomposition was used to separate these material from each other.
Excised fresh sheep’s heart was bluntly dissected (Figure 6.4) and scanned with above
mentioned imaging protocol. Material decomposed images were created.
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Figure 6.4: Sheep’s heart sample preparation. a. Blunt dissection to remove non cardiac
tissue. b. Evaluation of intactness of anatomical structures. c. Repairing of local tear.
Results
Figure 6.5: Sheep Heart Axial section. A: Photographic image. B: MARS MD image.
Gross external and internal structures of heart were evaluated. Pericardial fat, cham-
bers of heart , chordae tendinae, papillary muscles were clearly visible (Figures 6.5, and
6.6) in MARS imaging. Similarly valvular structure of the heart and fatty deposition
along the wall of great vessels were also appreciated.
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Figure 6.6: MARS MD images. a. Internal structure of heart. b. Fat deposition on the inner
wall of aortic root
Conclusion
This study demonstrated that MARS scanner have an ability to scan fairly large bi-
ological object like sheep’s heart. Furthermore, due to its better spatial resolution
MARS imaging can differentiate minute anatomical details of heart like chordae ten-
denie and papillary muscles with greater clarity. Also, material decomposition allows
us to identify the early stage of atherosclerotic plaque (fatty streak) on the root of
the aorta (Figure 6.6). These findings gave us confidence to perform in-vivo imaging
.
6.6 Human scanning
There was a doubt on our ability to scan patient’s neck because of relatively longer
scanning time and hardware issues like possibility of rotating gantry coming across
patient shoulder during scanning. Apart from that we were still unsure about the
effect of arterial pulsation on the image quality. So, our team decided to scan human
knee prior to the neck because it has almost same diameter as neck and the caliber of
limb’s arteries more or less resemble that of carotid artery in their diameter (Figure
6.7).
6.6.1 MARS imaging of patient’s knee
This was a known case of atherosclerotic disease of bilateral lower limbs. Right lower
limb just below knee joint was scanned as per previously described imaging proto-
col.
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Methodology
Calibration phantoms containing different concentrations of hydroxyapatite (HA) were
scanned to find the optimal linear relationship between different HA concentration and
the output CT signal in Hounsfield Units (HU), forming a calibration curve (Figure
6.2).Thereafter, right knee of patient was scanned.
Findings
As shown in Figure 6.7, vascular wall of posterior tibial and peroneal arteries, both
calcified and non calcified, were clearly visible.
Figure 6.7: Coronal MARS MD image shows hydroxyapatite/ calcium signal (white), lipid
(yellow) and water/ soft tissue (red). Since tissue is made up of various concentration of fat
and water, muscle appear brownish in the image.
Conclusion
This scan showed that in MARS can delineate in-vivo human artery and led to next
scan, neck of a stroke patient.
6.6.2 Neck scanning
On 20/10/2020, we scanned neck of a patient with history of stroke. A 60 years old male
patient with a history of atherosclerotic disease was requested by a treating surgeon to
undergo MARS scan of carotid arteries.The patient also had have right endarterectomy
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two years ago. On followup Doppler study he had luminal stenosis of about 50% in his
left carotid artery.
Methodology
First we scanned phantoms containing different concentrations of hydroxyapatite (HA),
lipid and water with above mentioned imaging protocol to calibrate the scanner. There-
after, patient’s neck , about 4.0 cm below the angle of mandible, was scanned. It took
around 20 minutes for us to scan the neck. Scanning was done on the supine position
with head flexed slightly to minimise field of view.
Findings
Figure 6.8: Axial section of suprahyoid region of neck. Material decompose image. In the
image, fat, calcium , and water are represented by yellow, white and red respectively. Since
tissue is made up of various concentration of fat and water, muscle appear brownish in the
image. Arrowhead in the left side of the image shows calcified carotid wall.
With this image we were able to demonstrate that
1. Complex structure like neck can be scanned with MARS scanner in relatively
reasonable period of time (about 20 min).
2. Pulsating artery can be scanned without significant motion artifact.
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Conclusion
This was a major milestone in carotid imaging as we were able to scan a patient with
SPCCT for the first time, resolving many anticipated technical hurdles.
6.7 Summary of the chapter
The main aim of these studies explained in this chapter was to scan in-vivo carotid
artery of patient in MARS scanner. Three major anticipated challenges before starting
the study were,
• Technical ability of MARS scanner to scan large object.
• Visibility of artery which is surrounded by soft tissue.
• Possibility of motion artifact in pulsating artery.
Four separate studies were conducted. First three were preparatory experiments for
final scan of patient’s neck. Scanning of fresh sheep’s heart assured us an ability of
MARS SPCCT to scan large complex object like heart. Scanning of carotid artery
placed inside the popliteal fossa of lamb’s knee, mimicking in-vivo condition, gave
valuable information regarding the effect of surrounding soft tissue in identification of
arterial contour. In third experiment we scanned patient ’s knee with known atheroscle-
rotic disease. Knee was chosen for imaging because its diameter is close to that of the
neck. Beside that, caliber of knee arteries more or less resemble carotid artery. This ex-
periment reassured that superficially located pulsatile artery in-vivo could be scanned
in MARS SPCCT scanner. This scanned led us to third scan, neck of stroke a patient
which lasted for around 20 min. We were able to scan whole diameter of neck and




This thesis shows an ability to differentiate different constituents of atherosclerotic
plaques, which other studies have shown to be associated with plaque vulnerability.
Evidence acquired in these studies are of huge clinical importance since there is no single
imaging modality which can predict vascular insufficiency with certainty. Currently
recommended tools are either partially effective in risk stratification or only useful in
post incidence damage evaluation.
7.1 Review of achievements reported in this thesis
During the period of this study, excised atherosclerotic plaques were extensively eval-
uated for different structural parameters to explore an effectiveness of MARS SPCCT
in identification of rupture prone plaque.
Chapter 2 found that there was no significant difference between SPCCT and histopatho-
logical measurements of fibrous cap thickness, fibrous cap area and lipid rich necrotic
core area in ex-vivo carotid atherosclerotic plaque. These findings demonstrate the ef-
fectiveness of SPCCT in soft tissue imaging which is so far considered as prerogative of
MR imaging. Even though significant amount of work is needed to be done to achieve
MR quality images, this study establishes yet another potential imaging modality for
soft tissue imaging.
Chapter 3 demonstrates that MARS SPCCT can identify and locate intra-plaque iron
as a sign of micro-haemorrhage. As mentioned earlier, this result, if consistent with
large multi-centric clinical trials, will set a new paradigm in diagnostic imaging as ex-
isting CT technology identify hemorrhage based on the attenuation characteristics of
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protein content of haematoma which is not consistent and changes with age of blood
clot.
In Chapter 4, it was observed that lower energy (<45 keV) X-ray beam overestimated
the actual size of the plaque calcification. This was a crucial finding relation to the
energy of X-ray beam that must be used for precise quantification of intraplaque calcifi-
cation, which is an important bio-marker of plaque instability. The evidence produced
in this study has directly contributed to the current clinical trial in our group.
Similarly, Chapter 5 shows effectiveness of MARS SPCCT in identification of vas-
cular calcification in plastinated aortic valve samples. The results we obtained in this
study was very helpful for our local collaborators who wanted to know the potential
effect of plastics in imaging.
The most important part of this thesis is Chapter 6 which illustrates the imaging
of patient with carotid pathology, a milestone in carotid imaging.
7.2 Research with traslational ability
Diagnostic imaging is an extremely sophisticated technology, which includes hardware
as well as software development requiring years of incremental growth. Nevertheless,
creating evidence in the lab and translating them for patient care within this short
span of time (Chapter 6) is another major achievement of this thesis work. It is worth
mentioning that credit goes to whole MARS team, of which I am part of, who have
been working tirelessly for years to make this possible.
7.3 Opportunities for new PhD student
No study is complete in itself and there is always scope to grow. Moreover, some of
them pave ways for greater exploration. In my opinion, there are three main areas for
a prospective PhD student to investigate:
1. Imaging of pathophysiological changes that occur in atheroscle-
rotic plaque
Migration of monocytes to the plaque is a sign of local inflammation making it vulner-
able to rupture. Imaging of macrophages aggregation in the plaque site with potential
use of heavy metal contrast material may be helpful in determining extent of inflam-
mation in the plaque.
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2. Quantitative analysis of intraplaque haemorrhage
In this thesis, intraplaque haemorrhage was qualitatively evaluated, as a proof of the
concept. However, to generate stronger evidence, clinical studies with more robust
research design should be performed.
3. Clinical trials
Future student could design and execute research in human subjects to gather infor-
mation about effectiveness of MARS spectral photon counting CT in atherosclerotic
patients.
7.4 Future possibilities that exist in this field
As stated earlier, this research shows the potential of MARS SPCCT in differentiat-
ing vulnerable rupture prone plaque from stable ones. Furthermore, it demonstrates
the translational ability of MARS technology from lab scanner to full-fledged clinical
machine, leading us to new era of research and innovation. Following are the future
possibilities that might exist in this field,
Synergism with existing diagnostic tools
1. Hybrid Imaging
Comparative study with existing imaging modalities will not only be useful in identi-
fying strength or limitations of SPCCT vis-à-vis US, CT, MRI or PET scan, but can
also be helpful in exploring synergistic effect of these imaging tools when they are com-
bined with each other. This multi-imaging approach, known as a hybrid imaging, could
significantly increase diagnostic accuracy in clinics allowing physicians to risk stratify
their patients and create opportunity to mitigate the disease Bing et al. (2019).
2. Incorporation of SPCCT images with clinical and laboratory findings to
develop robust diagnostic protocol
Diagnosis of vulnerable plaque includes identification of complex pathophysiological
changes that occur in the wall of medium and large sized arteries. Interpretation of
these findings for evaluation of plaque vulnerability is a challenging task as it involves
multiple factors, such as inflammatory, metabolic and degenerative process with dif-
ferent level of involvement in plaque pathology. Predisposing factors like gene, gender,
age, race and lifestyle also all play various roles in the development and progression of
the disease. Thus, a strong diagnostic protocol can only be developed by considering
the multi-factorial nature of the disease and combining bio-chemical or physiological
tests along with imaging, including SPCCT. For examples incorporation of different
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inflammatory markers ( e.g. C-reactive protein), predisposing factors like amount of
cholesterol in the blood along with imaging findings can create an effective protocol
needed for evaluation of the disease for appropriate treatment alternatives.
Continuous innovation
1. Further improvement of MARS scanner
MARS scanners we have now are faster, more accurate and more precise than what
we had few years ago. As a result, we were able to scan live human being and were
able to produce diagnostic quality images. However, technological development is an
ongoing process which needs constant improvement. Admittedly, our scanners need to
be improved for swift handling of tremendous amount of data that would be generated
during diagnostic imaging. Efficient processing of these data will reduce scanning time,
which is currently around 20 min /scan, and consequently minimize the possibility of
motion artifact while performing in-vivo scanning.
2. Research on effective contrast materials
Material decomposition (MD) in SPCCT allows the separation of intra-luminal contrast
material from surrounding vascular wall which can be helpful in image guided therapies
like plaque removal, stent placement or balloon dilatation. Besides that, there is a
possibility of multi-contrast imaging as MD can differentiate various contrast materials
from each other Moghiseh et al. (2016). Moreover, use of targeted nanoparticle as
a contrast materials could act as a molecular imaging, setting up a new paradigm
in diagnostic radiology in which evaluation can be done based on pathophysiological
process rather than static pathological event Cormode et al. (2010) Chhour et al.
(2016).
Evidence based medicine
Research to increase strength of evidence
Most of the studies explained in this thesis are lab based and observational. Conse-
quently, evidence produced by these experiments were of low quality. The Chapter 6
shows a successful transition of research from lab to clinics. Subsequently, research
deigns has been uplifted to case series which will produce comparatively stronger ev-
idence.In future, as we move from clinics to communities, research must be redesign
to produce high quality of evidence such as randomised control trials or cohort studies
(Figure 7.1) Sackett (1997).
112
7.4. Future possibilities that exist in this field
Figure 7.1: Evidence based medicine. A. Hierarchy of evidence.B. GRADE classification of
the quality of evidence.EBM=evidence-based medicine. GRADE=Grading of Recommenda-
tions Assessment, Development, and Evaluation. RCT=randomised controlled trial. *Quality
of study moves down one or two grades. †Quality of study moves up one or two grades. Djul-
begovic and Guyatt (2017)
Clinical utility
1. Public health approach
Rising geriatric population with chronic debilitating health conditions, increasing de-
mand of bed site scanning and soaring interventional procedures, all are driving to
the huge demand of computed tomography (CT) all over the world. Current market
value of CT scanner is USD 6.6 billion dollar which is expected to rise by 33% up to
8.8 billion dollars within five years, by the end of 2024 Forecast (2020). Interestingly,
contrary to other medical equipment, the short supply of CT scanner is not confined to
under developed countries, rather there is a huge disparity even among the rich coun-
tries of Organisation for Economic Co-operation and Development (OECD) in terms
of per capita CT scanner (Figure7.2). For example, in United Kingdom, the number
of CT scanner is three times less than OECD average. To overcome this shortage,
National health service (NHS) came up with a plan to build a massive infrastructure
of diagnostic imaging across United Kingdom NHS (2019) by 2024.
MARS scanners can be effective not only in the health care centres of resource con-
straints countries of Africa and Asia as a substitute of conventional CT scans but also




Figure 7.2: International comparison of the number of CT scanners per million population
in 2015 (or nearest year). The OECD average is calculated for the 34 OECD countries for
which data were available. The UK data used in this comparison are from 2014. Richards
et al. (2018).
2. Individualistic approach (Personalised medicine)
Imaging of nano-particles (untargeted or targeted) to specific cell types can be used to
personalise diagnostic imaging based on the specific pathology an individual is suffer-
ing from Moghiseh et al. (2018). This type of tailored medicine which includes both
diagnostic and therapeutic procedures could improve the patient care tremendously.
In summary, objectives of this thesis, to evaluate the effectiveness of MARS SPCCT in
plaque imaging and to explore its transitional ability for clinical application, have been
successfully achieved. Knowledge has been transferred from "bench-to bed side" (T1
translation). Now the challenge is to translate this research to enhance the adoption of
best practices in the community for cost effective prevention and appropriate treatment
strategies (T2 translation) Woolf (2008).
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Decalcification of excised carotid arteries was done with weak formic acid.
• 9% formic acid was mixed with 0.5%.
• Specimens were kept inside the solution for 24 hours.
• Thereafter, samples were neutralisation in saturated lithium carbonate solution for 1.5 hours.
A.2 Hematoxylin & Eosin (H&E) staining
Introduction:
H&E staining protocol is used for the routine staining of cationic and anionic tissue in the biological
specimen where hematoxylin stains the acidic part of the cell, Nucleus and the cytoplasm is stained
by Eosin.
Fixation:
Fixation was done in neutral buffered formalin then specimen were embedded in paraffin.
Staining:
Reagents:
1. Hematoxilin —————– 2 lit
2. Eosin Y 1% aqueous———2 lit
Procedure:
1. Slides were De-paraffinized to distilled water.
2. Slides were stained with the hematoxylin solution for 3 minutes, and washed in distilled water.
3. Thereafter stained with Eosin solution, 20 dips .
4. Slides were dehydrated in different concentration of alcohol.
5. They were cleared in xylene and were mounted in a synthetic mounting medium.
Results: Nucleus appeared ——– Blue
Cytoplasm——————–Red.
A.3 Alizarin Red staining
Introduction:
This is an anthraquinone derivative which is used to identify calcium in tissue sections. Calcium forms
complex with Alzarin red which appear orange red.
Fixation:
Fixation was done in neutral buffered formalin then specimen were embedded in paraffin.
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Alizarin Red Solution preparation:
Alizarin Red S (C.I. 58005) ———– 1 g
Distilled water ————————- 50 ml
Alzarin Red power was mixed well in distilled water. The pH was adjusted to 4.3 with 10% ammonium





Acetone (100%) ————————-25 ml
Xylene ———————————– 25 ml
Procedure:
1. Slides were De-paraffinized to distilled water.
2. Slides were stained with the Alizarin Red Solution for 3 minutes, and the reaction was observed
microscopically to see nice red-orange staining of calcium.
3. excessive dye was shaked off and sections were blotted .
4. Slides were dehydrated in acetone, 15 dips. Then in Acetone-Xylene (1:1) solution, 15 dips.
5. They were cleared in xylene and were mounted in a synthetic mounting medium.
Results:
Calcium deposits appeared ——– orange-red
This precipitate was birefringent.
A.4 Prussian blue staining
Introduction:
First, specimens are treated with acid solution. Then, they are applied with Ferrocyanide solution.
Ferric ions present in the tissue reacts with ferrocyanide forming a bright blue pigment called Prussian
blue or ferric ferrocyanides.
Fixation:
Fixation was done in neutral buffered formalin then specimen were embedded in paraffin.
Staining:
Reagents:
20% Aqueous Solution of Hydrochloric Acid:
Hydrochloric acid, concentrated ———— 10 ml
Distilled water —————————–40 ml
10% Aqueous Solution of Potassium Ferrocyanide:
Potassium ferrocyanide, Trihydrate——— 10g
Distilled water ————————— 50 ml
Working Solution:
Equal parts of 20% hydrochloric acid and 10% potassium ferrocyanide solution were mixed, just before
use.
Procedure:
1. Slides were De-paraffinized to distilled water.
2. Slides were stained in working solution for 30 min
3. Counter stained with Eosin for 5 min
4. Slides were dehydrated and were cleared in xylene thereafter mounted in a synthetic mounting
medium.











B.2 Spectral CT imaging of ex-vivo calcific aortic valve
disease
Figure B.3135
Figure B.4
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